Tinnitus Types: Tinnitus with Hearing Loss

Most people with tinnitus also have some hearing loss. Hearing aids and sound therapy can help with both problems at once.

  • Neuroplasticity and Tinnitus: How Your Brain Can Rewire Its Response

    Neuroplasticity and Tinnitus: How Your Brain Can Rewire Its Response

    Your brain made this. And your brain can change it

    If you have lived with tinnitus for months or years and been told there is nothing to be done, you are not alone. That message is increasingly out of step with what neuroscience actually shows. The frustration of sitting with a sound no one else can hear, while being handed a pamphlet about “learning to live with it,” is real. But there is a more complete story, and it starts with where tinnitus actually comes from.

    Tinnitus is not primarily an ear problem. A review published in The Lancet Neurology describes tinnitus as a brain disorder, one that arises when the auditory system reorganises itself after cochlear damage (damage to the hearing cells of the inner ear) (Langguth et al., 2013). The ear may be where the original injury happened, but the phantom sound you hear is generated in the brain’s rewired circuits. That reframing matters because it points toward something genuinely useful: the same biological process that created the tinnitus is, in principle, the mechanism through which treatments can work to reduce it.

    This article explains how the brain produces tinnitus through three distinct neuroplastic changes, what happens structurally when tinnitus becomes chronic, and which treatment approaches are designed to target each mechanism specifically. Understanding the “why” behind a given therapy is not just intellectually satisfying. It helps you set realistic expectations and engage more meaningfully with treatment.

    What is tinnitus neuroplasticity? (The short answer)

    Tinnitus neuroplasticity refers to the process by which the brain reorganises its auditory circuits in response to cochlear damage, generating a phantom sound in the process. When hearing cells are damaged, the brain receives less input from a particular frequency range. Rather than simply going quiet, it compensates: it amplifies its own internal signals, reassigns neurons, and loses some of its normal sound-suppression ability. The result is spontaneous neural activity perceived as ringing, buzzing, or hissing. Tinnitus neuroplasticity works in both directions. The same brain circuits that rewired themselves to produce tinnitus remain capable of further change, and several treatment approaches are designed to build on that capacity to reduce the phantom signal over time.

    Tinnitus is caused by the brain’s own reorganisation after cochlear damage (not a fixed defect, but the product of plastic circuits that can still change). Treatments that target these mechanisms work with the brain’s plasticity rather than against it.

    How the brain creates tinnitus: three mechanisms in plain language

    Neuroscientists have identified three interrelated changes in the brain that generate tinnitus after cochlear injury. They are not three separate failures; they are three facets of the same adaptive cascade (Wang et al., 2020). Understanding each one separately helps clarify why different treatments do different things.

    1. Central gain increase: the brain turns up its own volume

    Imagine a radio where the signal from the antenna has become very weak. The radio’s amplifier responds by cranking up the gain: suddenly you are hearing not just the station but the static and noise that were always there at a lower level. Something similar happens in the auditory brain after cochlear damage.

    When fewer signals arrive from the damaged cochlea, the auditory cortex (the brain region that processes sound) does not simply process less. It increases its own sensitivity to compensate, a process called central gain increase. Neurons in the auditory cortex fire more frequently even in the absence of external sound. This spontaneous hyperactivity is what you perceive as tinnitus (Langguth et al., 2013). Research also shows that high-frequency electrical activity patterns known as gamma-band oscillations (a type of brainwave pattern associated with active neural processing) in the auditory cortex increase following auditory deprivation, in a pattern analogous to central sensitisation in chronic pain, where the nervous system amplifies pain signals after an initial injury (Wang et al., 2020).

    Understanding auditory cortex tinnitus at this level, where the brain’s own amplification system is the source of the phantom signal, is what makes the central gain mechanism so important for treatment planning.

    2. Tonotopic map reorganisation: neighbours move in

    The auditory cortex is organised like a piano keyboard: different regions respond to different frequencies, from low to high. When cochlear damage silences a frequency range, the neurons tuned to that range stop receiving their normal input. Over time, those neurons are colonised by neighbours, cells tuned to adjacent, undamaged frequencies.

    The degree of tonotopic map reorganisation correlates with tinnitus severity: the greater the reorganisation, the more severe the tinnitus tends to be (Wang et al., 2020). Notably, some patients with clinically normal hearing can have tinnitus without any detectable tonotopic map change, suggesting this mechanism is prominent in noise-induced or age-related tinnitus but is not universal across all tinnitus subtypes (Eggermont, 2015).

    3. Loss of lateral inhibition: the silencing network breaks down

    In a healthy auditory system, active neurons suppress the activity of their neighbours through a process called lateral inhibition. Think of it as a “shushing” network: the neurons that are supposed to be firing keep nearby neurons quiet, maintaining the clarity and precision of sound perception. After cochlear damage, this inhibitory network weakens in the frequency regions deprived of input. Without that suppression, groups of neurons begin firing together in synchrony, generating a coherent neural signal that the brain interprets as a sound (even though no external sound exists).

    These three changes are interrelated. Central gain increase drives up background activity; tonotopic reorganisation redistributes which neurons are active; and the breakdown of lateral inhibition allows that activity to become a synchronised, perceivable signal. None of these mechanisms operates in isolation.

    When neuroplasticity goes structural: why chronic tinnitus is harder to treat

    The changes described above are functional: they involve how neurons fire and communicate. In chronic tinnitus, something more durable also happens. The brain physically changes its structure in ways that can be measured on an MRI scan.

    A meta-analysis of neuroimaging studies found grey matter increases in the superior temporal gyrus and angular gyrus, auditory regions of the cortex. This is consistent with use-dependent hypertrophy from chronic overactivation by the phantom sound (Dong, 2020). At the same time, grey matter decreases were observed in the nucleus accumbens (a region involved in reward processing and attention gating), the ventromedial prefrontal cortex (vmPFC), and the caudate nucleus (a region involved in the brain’s gating and reward circuitry). These regions are part of the brain’s gating circuit, the network responsible for deciding whether an incoming signal is relevant enough to reach conscious awareness.

    Rauschecker et al. (2010) proposed what is sometimes called the noise-cancellation model: the vmPFC and nucleus accumbens normally send signals that suppress the tinnitus percept at the level of the thalamus (the brain’s sensory relay centre), acting as a filter. When grey matter in these regions diminishes, this suppression weakens, and the phantom sound breaks through more persistently. In patients with chronic tinnitus following surgery, increased grey matter volume in the caudate nucleus has also been identified as a structural correlate of tinnitus that did not resolve (Trakolis et al., 2021).

    None of this means the damage is permanent. The brain retains plasticity throughout life. What it does mean is that structural remodelling takes longer to reverse than functional reorganisation, and that treatments targeting these circuits need time to work. This is also why acting earlier, before structural changes have consolidated, gives treatment a better chance of meaningful effect. If your tinnitus has persisted beyond a few weeks, a referral to an audiologist or ENT specialist is worth pursuing sooner rather than later.

    The structural changes described here are not irreversible, and they do not mean chronic tinnitus cannot improve. They do explain why chronic tinnitus typically requires more targeted approaches and longer treatment timelines than acute tinnitus.

    Working with plasticity: treatments that target the brain’s rewiring

    The clearest benefit of understanding tinnitus neuroplasticity is that it allows you to understand why a given treatment works the way it does, and what to realistically expect from it. Brain rewiring tinnitus research has produced several distinct therapeutic approaches, each targeting a different point in the adaptive cascade.

    Tailor-made notched music training (TMNMT): targeting lateral inhibition and tonotopic maps

    TMNMT involves listening to music from which a narrow band of frequencies around your tinnitus pitch has been removed (“notched”). The theory is that stimulating the frequencies on either side of the gap strengthens lateral inhibition in those adjacent regions, gradually suppressing the hyperactive neurons generating the phantom sound. Over time, this may also begin to reverse tonotopic map reorganisation by restoring competitive input to the deprived frequency zone.

    A foundational small study (n=16) cited in Wang et al. (2020) found that 12 months of TMNMT was associated with reduced tinnitus loudness and reduced auditory cortex response in the notched frequency region. A subsequent RCT with 100 participants found that the primary endpoint at three months was not met, but a delayed loudness benefit was observed at follow-up (Stein et al., 2016, doi:10.1186/s12883-016-0558-7). A further RCT comparing TMNMT with TRT in 120 participants provided additional effect-size data, though results were mixed (Tong et al., 2023).

    The current guidance picture is sober. NICE (2020) does not recommend TMNMT due to insufficient evidence. The results are mechanistically coherent and some patients report benefit, but TMNMT should be understood as a research-informed option, not an established clinical standard.

    TRT and CBT: targeting the limbic-attentional loop

    Tinnitus Retraining Therapy (TRT) and Cognitive Behavioural Therapy (CBT) do not directly target the auditory cortex. Instead, they work on the limbic-attentional loop: the emotional and evaluative systems that determine how much attention and distress the brain assigns to the tinnitus signal.

    From a neuroplasticity standpoint, this is habituation: the brain learns that the tinnitus signal does not require a threat response, and the limbic circuits gradually reduce their reactivity to it. This is adaptive plasticity of the emotional response rather than the auditory signal itself. NICE (2020) strongly recommends CBT for tinnitus distress based on consistent clinical trial evidence. The implication for patients is important: CBT does not make the sound quieter, but it changes what the brain does with the signal, which is a neuroplastic change in its own right.

    Vagus nerve stimulation (VNS) paired with tones: neuromodulatory gating of plasticity

    VNS paired with sound works differently from both of the above. VNS activates chemical messenger systems in the brain (including pathways involved in alertness and learning) that act as a kind of plasticity gate: when the nerve is stimulated at the moment a particular tone is played, the brain becomes more receptive to reorganising around that tone. In animal models of noise-induced tinnitus, this approach eliminated both the physiological signs and behavioural indicators of tinnitus (Wang et al., 2020).

    A pilot RCT in humans (Tyler et al., 2017) with 30 participants found subgroup benefit. A related bimodal device using tongue stimulation rather than cervical VNS (Lenire) received FDA De Novo approval in 2023 based on a pivotal trial in 112 participants, where the primary endpoint was not met in the full cohort but was met in the moderate-or-worse subgroup. Bimodal neuromodulation (tongue-based) and cervical VNS are distinct modalities that share a neuromodulatory mechanism but differ in their delivery method. Both remain early-stage research areas. NICE (2020) does not currently recommend either approach for tinnitus, and patients should understand this as a field where the science is developing rather than settled.

    A note on evidence levels: TRT and CBT have the strongest and longest-standing clinical evidence base for tinnitus. TMNMT and VNS/bimodal neuromodulation are mechanistically well-grounded and supported by early trial data, but both NICE (2020) and research consensus place them in the “needs more evidence” category for now. This is not a reason to dismiss them. It is a reason to approach them through qualified clinicians and, where possible, as part of research trials.

    Hearing aids and sound enrichment: dampening the central gain signal

    Hearing aids and background sound enrichment work on the central gain mechanism. By restoring auditory input to the frequency regions that have been deprived, they reduce the contrast between the cochlear signal and the brain’s expected input. This dampens the drive for central gain increase. Rather than simply masking the tinnitus, sound enrichment is actively reducing the stimulus that keeps the central gain elevated. This mechanism aligns closely with what the research describes as the initial trigger for all three maladaptive changes (Langguth et al., 2013).

    What you can do: practical implications for long-term tinnitus patients

    Knowing the mechanisms behind tinnitus is not just background reading. It changes how you can engage with treatment.

    • Understanding what TRT and CBT actually do helps set realistic expectations. These therapies target the limbic-attentional loop, not the auditory cortex. They are unlikely to make the sound disappear, but they can change how persistently the brain flags it as a threat, which is a meaningful and real improvement for many people.

    • Earlier intervention matters mechanistically. Structural grey matter changes consolidate over time, making the brain’s gating circuitry progressively harder to restore. If tinnitus has persisted beyond a few weeks, seeking an audiologist or ENT referral sooner rather than later is not just cautious. It is grounded in the biology of how plasticity works.

    • Hearing aids are not just masking devices. If you have accompanying hearing loss, hearing aids actively reduce the sensory deprivation that drives central gain increase. Wearing them consistently has a neuroplastic rationale.

    • Stress, sleep, and psychological state influence the limbic-attentional loop directly. Addressing sleep disruption, anxiety, and high stress is not simply managing symptoms alongside tinnitus. It is intervening in the same circuit that determines how persistently the brain attends to the phantom signal. This makes psychological and lifestyle support a genuine part of tinnitus neuroplasticity-based management.

    If you are currently waiting for a specialist appointment, be honest with them about how long the tinnitus has been present, whether it has changed over time, and what triggers make it more or less noticeable. That information helps clinicians target the most appropriate mechanism-level intervention.

    Conclusion: the same brain that made the sound can learn to quiet it

    The central insight of tinnitus neuroscience over the past two decades is this: tinnitus is not a broken ear sending a wrong signal. It is a brain that reorganised itself after cochlear damage, and the reorganisation itself is the signal. That is a significant reframe. Not because it makes tinnitus easier to bear immediately, but because it points toward a real lever for change.

    The plastic circuits that produced central gain increase, tonotopic map reorganisation, and the loss of lateral inhibition remain capable of further change. Structural remodelling takes longer to address than functional rewiring, which is why earlier treatment tends to produce better outcomes and why chronic tinnitus requires patience and targeted approaches. The biology does not suggest a closed door.

    If your tinnitus has persisted for more than a few weeks, the most productive next step is a specialist assessment. An audiologist or ENT who can evaluate the type and characteristics of your tinnitus and discuss which treatment approach is most appropriate for your situation. The science is not yet at the point of guaranteed resolution, and no single therapy works for everyone. What it does offer is a mechanistically coherent framework for why specific treatments can reduce, if not eliminate, the phantom sound, and that is a meaningful foundation to build on.

  • Ear Candles for Tinnitus: Why They Don’t Work and What the Risks Are

    Ear Candles for Tinnitus: Why They Don’t Work and What the Risks Are

    Do Ear Candles Work for Tinnitus? The Short Answer

    Ear candles do not relieve tinnitus. No controlled study has found any benefit, the FDA has formally warned against their use, and the procedure can make tinnitus worse by depositing wax in the ear canal or perforating the eardrum.

    The mechanism behind ear candling (that a burning hollow candle creates negative pressure to suck out earwax) has been tested directly and found to generate no measurable suction at all (Seely et al. (1996)). The brown residue visible inside used candles, often taken as proof that something was extracted, is composed of burned candle wax and fabric. Studies have detected no cerumen in it. The NHS states plainly: “There’s no evidence that ear candles or ear vacuums get rid of earwax” (National). The FDA’s formal position, issued in 2010, is that “there is no valid scientific evidence for any medical benefit from their use” (U.S. (2010)).

    What Ear Candles Claim to Do — and Why the Mechanism Doesn’t Hold Up

    Ear candling involves lying on your side while a hollow cone of beeswax-coated fabric is inserted about a centimetre into the outer ear canal. The far end is lit, and the candle burns for roughly 15 minutes. Proponents claim the flame creates a vacuum that draws earwax and other debris up through the canal and into the candle.

    The physics of this don’t hold up. In a controlled study using tympanometric measurements in an ear canal model (a method sensitive enough to detect very small pressure changes) Seely and colleagues found that ear candles produce no negative pressure whatsoever (Seely et al. (1996)). In a small clinical trial of 8 ears, no cerumen was removed from any subject. In some cases, candle wax was deposited onto the eardrum instead.

    The residue question is worth addressing directly, because it’s the single most persuasive-looking piece of evidence for the practice. After candling, users see a dark, waxy material inside the spent candle and reasonably assume it came from their ear. When researchers analysed this material, they found burned candle wax and charred fabric, not cerumen. You would find the same residue if you burned the candle in open air, with no ear involved at all.

    A 2004 critical review of all available evidence on ear candling concluded: “There is no data to suggest that it is effective for any condition. Furthermore, ear candles have been associated with ear injuries. The inescapable conclusion is that ear candles do more harm than good. Their use should be discouraged” (Ernst (2004)).

    Why Ear Candles Can’t Treat Tinnitus Specifically

    Tinnitus has many causes, and understanding them matters here. Most tinnitus is neurological in origin: the auditory system generates phantom sound because of changes in how the brain processes hearing signals, often following noise damage or age-related hearing loss. This type of tinnitus has nothing to do with earwax, and no earwax intervention of any kind will affect it.

    A smaller proportion of tinnitus cases are conductive in nature, meaning the sound perception is linked to something blocking or interfering with the transmission of sound through the outer or middle ear. Earwax impaction is one recognised cause of conductive tinnitus, which is why some patients reasonably consider earwax removal as a first step.

    Ear candling fails even in these cases, for two reasons. First, as the evidence above shows, it doesn’t actually remove earwax. Second, the anatomy matters: a candle placed in the outer ear canal cannot reach the middle ear or inner ear, both of which are sealed off by the eardrum. The structures where most tinnitus originates are physically inaccessible to any external canal procedure.

    The American Academy of Otolaryngology’s clinical practice guideline on cerumen impaction explicitly identifies ear candling as contraindicated. Michaudet & Malaty (2018), writing in American Family Physician, advise that “cotton-tipped swabs, ear candling, and olive oil drops or sprays should be avoided” in the context of cerumen management. These are not cautious qualifications — they are direct contraindications from the clinical bodies whose job it is to manage exactly the condition ear candles claim to treat.

    Ear candling is explicitly contraindicated by clinical guidelines for cerumen management. This means it is not just unhelpful — it is actively discouraged by the medical professionals who treat ear and hearing problems.

    The Risks: How Ear Candles Can Make Tinnitus Worse

    This is the part that often goes unmentioned in discussions of ear candling. The conversation usually stops at “it doesn’t work.” What matters just as much for tinnitus patients is that ear candles carry specific, documented risks of causing or worsening tinnitus.

    Candle wax deposited in the ear canal

    Because a lit candle drips, hot wax can fall into the ear canal. This doesn’t just fail to clear blockage — it creates new blockage. A canal newly obstructed by candle wax can trigger or worsen conductive tinnitus in exactly the same way that cerumen impaction does. A 2012 case report documented candle wax deposited directly onto the eardrum of a 4-year-old girl following ear candling. The deposits were initially mistaken for a pathological finding until the child’s medical history revealed the candling (Hornibrook (2012)). The survey of 122 ear, nose, and throat specialists conducted by Seely and colleagues identified 7 cases of canal blockage from candle wax among the injuries reported (Seely et al. (1996)).

    Thermal burns to the ear canal

    The skin of the ear canal is thin, sensitive tissue. The area close to the eardrum is especially so. Seely’s survey identified 13 burn injuries to the outer ear and ear canal among the adverse events reported by ENTs (Seely et al. (1996)). Burns to ear canal tissue can cause damage that affects hearing and, potentially, produces or aggravates tinnitus. The FDA has received reports of burns from ear candle use, and notes that injuries are likely underreported (U.S. (2010)).

    Eardrum perforation

    Hot wax reaching the eardrum can perforate it. A perforated tympanic membrane alters how sound is conducted to the inner ear and can produce new, sometimes permanent, tinnitus. The FDA has received reports of punctured eardrums from ear candle use (U.S. (2010)). Seely’s survey recorded one tympanic membrane perforation among the injuries reported (Seely et al. (1996)).

    Fire risk

    A lit candle held near hair and bedding while a person lies still creates a clear fire hazard. Burns to the scalp, face, and bedding have been reported. This is not tinnitus-specific, but it belongs in any honest accounting of the risks.

    Ear candles don’t just fail to help tinnitus — they carry specific risks of making it worse. Wax blockage, eardrum perforation, and thermal burns are all documented injury types with clear pathways to new or worsened tinnitus.

    If Earwax Is Contributing to Your Tinnitus: What Actually Works

    If you’re wondering whether earwax might be part of your tinnitus, that’s a reasonable question. Earwax impaction genuinely can cause tinnitus, and if it is a factor in your case, there are safe, effective ways to address it.

    The starting point is getting a proper assessment. A GP or audiologist can look directly into your ear canal and tell you whether significant wax is present. Tinnitus has many causes, and attempting earwax removal when wax isn’t the issue won’t help and could irritate already-sensitive tissue.

    If earwax impaction is confirmed, three approaches have good evidence behind them:

    Cerumenolytic drops Softening the wax with drops (olive oil, almond oil, or sodium bicarbonate solution) allows it to migrate out of the canal naturally over several days. The NHS recommends applying 2 to 3 drops of olive or almond oil to the affected ear three to four times daily for three to five days (National). This is a gentle first step appropriate for most people.

    Irrigation (syringing) A GP can flush the ear canal with a controlled stream of water to remove softened wax. This is a standard, effective procedure for most cases of cerumen impaction. It is typically preceded by a few days of oil drops to soften the wax first.

    Microsuction Performed by audiologists and ENTs, microsuction uses a fine suction probe to remove wax under direct visual guidance. It is the preferred method for people with narrow ear canals, a history of ear surgery, or a suspected perforated eardrum, because it avoids water entering the middle ear. Michaudet & Malaty (2018) and the NHS both list microsuction among recommended removal approaches.

    If you’ve been told in the past that there’s nothing that can be done about earwax, it’s worth asking your GP or audiologist specifically about microsuction. It’s not always available at every GP practice, but audiologists and ENT departments offer it routinely.

    One point worth keeping in mind: even if earwax removal resolves a blockage, tinnitus caused by other mechanisms (noise-induced hearing loss, for example) won’t change. A proper assessment gives you an accurate picture of what’s actually going on.

    Conclusion

    Ear candles have no evidence of benefit for tinnitus. They cannot generate suction, they do not remove earwax, and the residue that looks like extracted debris is candle wax. Both the FDA and clinical audiology bodies have formally rejected their use, and documented injuries include exactly the kinds of ear damage that cause or worsen tinnitus. Looking for natural, accessible solutions when you’re struggling with tinnitus is completely understandable — but this particular option poses real risks with no compensating gain. The most useful next step is a conversation with your GP or audiologist: they can check whether earwax is genuinely contributing to your tinnitus and, if so, remove it safely using methods that actually work.

  • Zinc for Tinnitus: Does the Evidence Support the Hype?

    Zinc for Tinnitus: Does the Evidence Support the Hype?

    Does Zinc Help Tinnitus? The Short Answer

    Zinc supplementation does not improve tinnitus symptoms in adults without confirmed zinc deficiency. A Cochrane review of three randomised controlled trials found no significant benefit across any measured outcome, and current clinical guidelines explicitly advise against recommending it for persistent tinnitus. The AAO-HNS Clinical Practice Guideline states that clinicians should not recommend zinc or other dietary supplements for treating patients with persistent, bothersome tinnitus (Tunkel et al. (2014)). If you’ve read elsewhere that zinc is worth a try, that advice is not supported by the weight of clinical evidence.

    Why Zinc Sounds Plausible: The Biology Behind the Hype

    Zinc is genuinely present in high concentrations in the cochlea, particularly in the stria vascularis and organ of Corti. Inside the inner ear, it acts as an antioxidant cofactor and modulates NMDA receptor activity in the auditory pathway. These are real biological functions, not marketing spin. The cochlea, unlike most tissues, depends on a precise chemical environment to convert sound waves into nerve signals, and zinc is part of that environment.

    Observational research has found that some tinnitus patients have lower serum zinc levels than healthy controls. A study by Ochi et al. (2003) compared 73 tinnitus patients to matched controls and found that patients with normal hearing had significantly lower serum zinc than controls, though the overall group difference did not reach statistical significance (P=0.06). This kind of data is what fuels the ‘zinc and tinnitus’ narrative online.

    The problem is that a biological role and an observational correlation are not the same as clinical efficacy. The relevant question isn’t whether zinc matters to cochlear biology. It’s whether giving zinc supplements to people with tinnitus improves their symptoms. On that question, the controlled trials are clear.

    One further wrinkle: serum zinc may not reliably reflect zinc concentrations in the inner ear itself. No study has directly compared blood zinc to cochlear zinc levels. Ochi et al. (2003) illustrated this indirectly by showing that the serum zinc picture changes depending on whether a patient also has hearing loss. This matters because much of the observational research uses serum zinc as a proxy for cochlear zinc status, and that assumption may not hold.

    What the Clinical Trials Actually Found

    The Cochrane review by Person et al. (2016) is the most thorough synthesis of the evidence. It included three randomised controlled trials with 209 participants in total and rated the evidence quality as very low for every outcome measured, including tinnitus severity, tinnitus loudness, and disability. No trial showed a statistically significant improvement.

    Here is how the individual trial results broke down:

    StudyPopulationOutcome measuredResult
    RCT in elderly patients (n=109)Older adults with tinnitusTinnitus Handicap Questionnaire5% vs 2% improvement (zinc vs placebo), RR 2.53, 95% CI 0.50–12.70: not significant
    Smaller RCT (n=50)Tinnitus patientsSeverity score (0–7 scale)MD -1.41 (95% CI -2.97 to 0.15): not significant
    Smaller RCT (n=50)Tinnitus patientsSeverity score (0–10 scale)8.7% vs 8.0% improvement, RR 1.09 (95% CI 0.17–7.10): not significant
    Yeh et al. (2019)20 NIHL patientsTHI score and audiometric measuresTHI improved (38.3 to 30, p=0.024); hearing thresholds, tinnitus frequency, tinnitus loudness: no significant change

    The Yeh et al. (2019) result deserves careful reading. On the surface, the 85% of participants who showed improved Tinnitus Handicap Index scores looks positive. But every objective audiometric measure, including hearing thresholds, tinnitus frequency, and tinnitus loudness, remained unchanged. Serum zinc did increase significantly after treatment, confirming the supplement was absorbed. Yet the ringing itself, measured objectively, was unaffected.

    When a subjective questionnaire score improves while objective measurements don’t shift at all, that’s the pattern you’d expect from a placebo response. The Yeh study had no control group to rule this out. This is not a criticism of the patients who participated; placebo responses are real physiological phenomena. It is, however, a reason not to interpret the THI improvement as evidence that zinc works.

    Person et al. (2016) concluded: “We found no evidence that the use of oral zinc supplementation improves symptoms in adults with tinnitus.”

    The One Exception: When Zinc Deficiency Is Confirmed

    Here’s where the picture gets more specific. Yetiser et al. (2002) gave zinc supplementation (220 mg/day for two months) to 40 tinnitus patients with no placebo control. Across the whole group, there was no statistically significant improvement in tinnitus frequency or severity. But within the study was a small subgroup that showed a different result: all six patients who had confirmed hypozincemia (measurably low blood zinc) reported subjective improvement, a result that reached statistical significance on the Wilcoxon rank sum test.

    The authors concluded that zinc supplementation provided relief in those “who apparently had dietary zinc deficiency” (Yetiser et al. (2002)).

    This is a genuinely interesting signal, but it needs to be read carefully:

    • The subgroup had only six people. That is far too small to draw firm conclusions.
    • There was no placebo control in this study, so we cannot rule out placebo effect even in this subgroup.
    • No randomised controlled trial has specifically tested zinc supplementation in confirmed zinc-deficient tinnitus patients. That study has not been done.

    What this means practically: if you have tinnitus and suspect a nutritional deficiency, getting your zinc levels tested via a routine blood test is a reasonable conversation to have with your GP. If a genuine deficiency is confirmed, correcting it makes sense for your general health, and there is a hypothesis that it may help your tinnitus too. But taking zinc supplements without knowing your levels, hoping this exception applies to you, is not supported by the evidence.

    Serum zinc testing is a standard blood test your GP can request. Taking zinc supplements without confirmed deficiency is unlikely to help your tinnitus and carries a small risk of side effects at high doses, including nausea and interference with copper absorption.

    Newer Evidence: Zinc, Diet, and Tinnitus Risk

    A 2024 prospective cohort study shifts the zinc conversation in a different direction. Tang et al. (2024) followed 2,947 adults aged 50 and over for 10 years and looked at whether dietary nutrient intake was associated with developing new-onset tinnitus. For zinc, the finding was clear: people whose dietary zinc intake was low (8.48 mg/day or below) had a 44% higher risk of developing tinnitus over the follow-up period (HR 1.44, 95% CI 1.07–1.93).

    That is a meaningful association, and it suggests that getting enough zinc through your diet matters for auditory health over the long term. The recommended daily intake for zinc is around 8–11 mg for adults, so the threshold in this study corresponds roughly to falling below the lower end of adequate intake.

    Good dietary sources of zinc include shellfish (particularly oysters), red meat, legumes, seeds, nuts, dairy, and whole grains.

    The important distinction here is between dietary adequacy and supplementation above need. Eating enough zinc to maintain normal levels is associated with lower tinnitus risk. Taking extra zinc when you already have tinnitus and already have adequate zinc levels has not been shown to treat or reduce the condition. These are two different questions with two different answers.

    Eating enough zinc through a balanced diet may help protect against developing tinnitus over time. Taking zinc supplements to treat tinnitus you already have is a separate question, and the clinical trial evidence does not support it.

    What the Guidelines Say

    The AAO-HNS Clinical Practice Guideline on tinnitus (Tunkel et al. (2014)) is direct: “Clinicians should not recommend Ginkgo biloba, melatonin, zinc, or other dietary supplements for treating patients with persistent, bothersome tinnitus.” This is a Grade C recommendation against zinc, based on a review of RCTs and systematic reviews showing inconsistent results and significant methodological concerns. The guideline acknowledges that some studies hinted at benefit in patients with underlying zinc deficiency, but concluded this was insufficient to support a general recommendation.

    Tinnitus UK reflects the same position in its patient-facing guidance, advising that supplements including zinc are not recommended for tinnitus.

    Guidelines like this exist for a practical reason: to protect patients from spending money on ineffective treatments while delaying access to approaches that genuinely work. Tinnitus affects sleep, concentration, and emotional wellbeing. The time and energy spent on supplements with no proven benefit is time not spent on therapies with real evidence behind them.

    What Actually Helps: Evidence-Based Alternatives

    If you’ve come to this article hoping zinc was going to be the answer, the honest response to your disappointment is: there are treatments that do have evidence behind them, and they work on the mechanisms that actually drive tinnitus distress.

    A network meta-analysis by Lu et al. (2024), covering 22 randomised controlled trials with 2,354 patients, ranked the effectiveness of non-invasive tinnitus treatments. Cognitive Behavioural Therapy (CBT) came out as the most effective approach for reducing tinnitus-related distress, with an 89.5% probability of ranking best on the Tinnitus Questionnaire. Sound therapy ranked as most effective for reducing Tinnitus Handicap Index scores (86.9% probability of best ranking). Combining both approaches is likely the strongest option for chronic tinnitus.

    For many people with tinnitus, the sound itself doesn’t disappear, but the distress it causes can reduce substantially. CBT addresses the emotional and attentional responses that make tinnitus feel unmanageable. Sound therapy works by reducing the contrast between the tinnitus signal and background sound, helping the brain habituate over time.

    Other evidence-based options worth discussing with a healthcare professional include:

    • Hearing aids, where tinnitus co-exists with hearing loss. Amplifying external sound often reduces the perceived intensity of tinnitus.
    • Tinnitus Retraining Therapy (TRT), which combines sound therapy with counselling.
    • An ENT or GP evaluation to rule out treatable underlying causes, including genuine nutritional deficiencies, ear conditions, or medication-related effects.

    If you’ve already tried zinc and felt some improvement, that experience is real. Placebo responses involve genuine changes in how the brain processes sensation. What the evidence tells us is that zinc itself is unlikely to be the active ingredient. The improvements some people notice are the kind that CBT and structured sound therapy can produce more reliably, and with a proper evidence base behind them.

    Conclusion

    Zinc is not recommended for tinnitus unless blood tests confirm you have a genuine zinc deficiency. The most practical step you can take is to speak with your GP: they can test your zinc levels, rule out other contributing causes, and point you toward the approaches that have the strongest clinical evidence. Living with tinnitus is genuinely hard, and reaching for something natural with a plausible-sounding mechanism is completely understandable. You deserve a straight answer about what the evidence says, and the straight answer here is that your time and energy are better invested in CBT or sound therapy than in zinc supplements.

  • Tinnitus and Hearing Aid Costs: What Insurance Covers in 2025

    Tinnitus and Hearing Aid Costs: What Insurance Covers in 2025

    Why Hearing Aids Are Recommended for Tinnitus

    With dozens of tinnitus treatments available, knowing which ones have real evidence behind them helps you make informed choices, and hearing aids are near the top of that list when hearing loss is involved.

    Approximately 90% of people with chronic tinnitus have co-existing hearing loss, and both the American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS) and major clinical guidelines recommend an audiological evaluation as a first-line step when that hearing loss is documented. The logic is straightforward: when your ears are under-amplifying, your brain compensates by turning up its internal gain, and that’s part of what generates the phantom sound.

    The frustration most patients feel is real. You’ve been told hearing aids may help, you’ve looked up the price, and now you’re wondering how on earth you’ll pay for them. Understanding what you’ll actually pay, and what your insurance will or won’t cover, is exactly the right question to ask before you commit to anything. This article gives you the honest picture.

    How Much Do Hearing Aids for Tinnitus Cost in 2025?

    Prices span a wide range depending on technology level, whether you need a prescription, and whether professional fitting services are included.

    OTC hearing aids: $650–$1,800 per pair

    Since the FDA legalised over-the-counter hearing aids in 2022, adults with mild to moderate hearing loss can buy devices without a prescription or audiologist visit. Entry-level OTC options start around $649 per pair. These are a reasonable starting point for people with mild-to-moderate hearing loss who want to try amplification before committing to a full audiology workup.

    Mid-range prescription devices: $1,800–$3,500 per pair

    This tier includes Costco hearing centres, where rebranded devices run $1,499–$1,599 per pair, significantly below private practice retail prices. Mid-range prescription devices typically include professional fitting and follow-up visits, which adds value even if the device itself costs less.

    Premium prescription devices with tinnitus sound therapy: $3,500–$6,000 per pair

    Top-tier prescription devices include built-in tinnitus sound therapy programs. Based on current market data, the Oticon Intent is priced from approximately $4,898 per pair, the Phonak Audéo Infinio from approximately $3,998, and the Signia Active Pro IX from approximately $2,348. The average amount hearing aid users actually pay is around $4,672 per pair, based on survey data from HearingTracker users, though that figure comes from a self-selected group and may not represent all buyers.

    Combination instruments: premium tier

    Combination instruments bundle a hearing aid with a dedicated built-in sound generator for structured sound enrichment. They sit at the top of the price range and are discussed in more detail in the next section.

    A key point on total cost: the device price is only about one-third of what you’ll spend. Professional fitting, hearing evaluations, follow-up appointments, and ongoing audiological services make up the rest. When comparing quotes, always ask for an itemised breakdown.

    OTC devices start at $649/pair. Average paid for prescription hearing aids is around $4,672/pair. But the device alone is roughly one-third of your total cost — professional services account for the rest.

    What Tinnitus Feature Should You Pay Extra For?

    If you’re looking at a $4,898 device versus a $2,348 device and both claim to address tinnitus, you deserve an honest answer about whether the premium features are worth it.

    The short answer: probably not, for most people.

    A 2019 randomised controlled trial (Yakunina et al. (2019), n=114) compared three different hearing aid types, conventional amplification, frequency translation, and linear frequency transposition, in patients with high-frequency hearing loss and tinnitus. At three months, 71% to 74% of participants across all three groups achieved a clinically meaningful improvement in tinnitus distress scores (at least a 20% reduction on the Tinnitus Handicap Inventory). There was no statistically significant difference between device types.

    A separate RCT (Henry et al. (2017), n=55) compared conventional hearing aids, extended-wear hearing aids, and combination instruments that include dedicated sound generators. All three groups showed substantial, clinically meaningful tinnitus relief. The combination instruments produced the numerically highest TFI improvement score, but the difference was not statistically significant. The study concluded there was insufficient evidence to favour any single device type. The Henry study was relatively small (55 participants), so the null result may partly reflect limited statistical power rather than confirmed equivalence.

    Practical takeaway: a well-fitted standard hearing aid often delivers tinnitus relief comparable to a premium combination device. Before paying extra for built-in fractal sound programs or dedicated noise generators, ask your audiologist whether there’s a specific clinical reason you’d benefit from those features. Save the premium spend for cases where standard amplification hasn’t provided enough relief.

    Some patients do benefit from structured sound enrichment programs, particularly those who don’t respond to amplification alone. If your audiologist recommends a combination instrument for a specific clinical reason, that’s different from buying the most expensive model by default.

    Does Insurance Cover Hearing Aids for Tinnitus?

    This is the section most cost comparison articles skip over. Here is the full picture.

    Traditional Medicare (Parts A and B)

    Traditional Medicare does NOT cover hearing aids, full stop. The Centers for Medicare and Medicaid Services (CMS) classifies tinnitus masking as experimental under National Coverage Determination 50.6, which means devices prescribed specifically for tinnitus relief are excluded from coverage.

    Medicare Part B does cover diagnostic hearing tests when a physician orders them for a medical condition such as tinnitus. In 2025, that means Medicare pays 80% of the approved amount after the annual Part B deductible ($257 in 2025). Coverage of the test does not extend to coverage of any device purchased afterward.

    Medicare Advantage (Part C)

    Medicare Advantage plans are required to cover everything traditional Medicare covers, but many go further with supplemental hearing benefits. Based on current plan data, approximately 97% of Medicare Advantage plans offer some hearing benefit, typically ranging from $500 to $2,500 per ear per year. Check your specific plan’s Evidence of Coverage document, as benefit amounts, eligible providers, and whether OTC devices qualify all vary by plan.

    Private insurance

    Most private health insurance plans do not cover hearing aids for adults. Only five US states currently mandate private insurer coverage of hearing aids for adults: Arkansas, Connecticut, Illinois, New Hampshire, and Rhode Island. Even in those states, employer self-funded plans (which are governed by ERISA federal law rather than state insurance law) are exempt from this mandate, so the coverage depends on whether your employer opts in.

    Tinnitus is classified as a non-covered diagnosis by most major US insurers. Even when hearing loss is the underlying condition, insurers typically exclude the device itself from benefits.

    Medicaid

    Medicaid hearing aid coverage varies significantly by state. Most states cover hearing aids for children and young adults under 21. Coverage for adults over 21 varies; approximately 30 states offer some form of adult Medicaid hearing benefit, though limits on device cost and frequency of replacement apply. Check your state’s Medicaid agency directly for current rules.

    FSA and HSA

    This is the most reliable cost-reduction tool for people without insurance coverage. Hearing aids qualify as eligible medical expenses under IRS Code Section 213(d), which means you can pay for them with pre-tax FSA or HSA dollars (BuyFSA (2025)). Eligible expenses include the hearing aids themselves (both prescription and OTC), batteries, cleaning kits, hearing evaluations, and audiologist services.

    In 2025, HSA contribution limits are $4,300 for individuals and $8,550 for families (plus a $1,000 catch-up contribution if you’re 55 or older). Unlike FSA funds, HSA money rolls over year to year with no expiration, so you can save across multiple years to cover the cost of a full prescription fitting.

    VA benefits

    Veterans with service-connected hearing loss or tinnitus may receive hearing aids at no cost through VA audiology. This is one of the strongest coverage pathways available. One significant change to be aware of: as of April 2025, the VA reportedly no longer accepts standalone tinnitus disability ratings for new claimants. This change is sourced from a commercial hearing care website rather than an official VA announcement, so veterans should verify their specific eligibility directly with their regional VA office.

    Traditional Medicare (Parts A and B) does not cover hearing aids. CMS classifies tinnitus masking as experimental. Check your Medicare Advantage Evidence of Coverage or contact your state’s SHIP counselor for a plan comparison before assuming you have hearing benefits.

    How to Reduce Out-of-Pocket Costs

    Even without insurance coverage, there are concrete ways to lower what you pay.

    Use FSA or HSA funds. If your employer offers an FSA or your health plan is HSA-eligible, this is your most direct savings tool. Paying $3,998 with pre-tax dollars saves you $800–$1,200 depending on your tax bracket, compared with paying out of pocket after taxes.

    Start with OTC if your hearing loss is mild to moderate. An OTC device at $649–$800 per pair lets you test whether amplification helps your tinnitus before committing to a $4,000+ prescription fitting. If the OTC device provides meaningful relief, you may not need to go further.

    Consider Costco hearing centres. Costco offers rebranded name-brand prescription devices at $1,499–$1,599 per pair, which is significantly below private practice retail. The trade-off: some users in patient forums report that Costco audiologists may not always enable tinnitus-specific sound therapy features. If you rely on those features, confirm with the Costco hearing centre before purchasing.

    Take advantage of trial periods. Many manufacturers offer 30 to 60-day risk-free trials. Use the trial period to evaluate whether the device genuinely reduces your tinnitus distress before the return window closes.

    Request an itemised quote. Hearing aid prices often bundle device cost, fitting, follow-up visits, and warranty together. Ask your audiologist to break these out separately, as in some cases you can unbundle services and pay only for what you need.

    Check employer group plan benefits. Some employer health plans include a hearing benefit rider that isn’t prominently advertised. Ask your HR department or benefits administrator directly.

    AARP hearing program. AARP members can access discounted hearing aids and audiological services through the AARP Hearing Solutions program.

    A well-fitted mid-range device with proper audiologist support consistently outperforms a premium device that isn’t set up correctly for your specific hearing profile.

    Bottom Line: What to Expect Before You Buy

    Hearing aids for tinnitus cost between roughly $650 (OTC) and $6,000 (premium prescription) per pair in 2025. Insurance coverage is limited: traditional Medicare excludes hearing aids entirely, private insurance rarely covers them for adults, and only five states mandate adult coverage. The most reliable financial tools are FSA and HSA accounts, which let you pay with pre-tax dollars and cover both devices and audiological services.

    On effectiveness: the evidence is real. In the Yakunina et al. (2019) RCT, 71% to 74% of participants achieved meaningful tinnitus distress reduction with standard hearing aids. About 60% of tinnitus patients report some relief overall. Hearing aids reduce distress and improve daily functioning (Schiele et al. (2025)), but they do not reliably reduce the perceived loudness of tinnitus itself, and individual response varies.

    Before you settle on a price tier, start with an audiological evaluation. Knowing your degree of hearing loss, your tinnitus profile, and your audiologist’s specific recommendation will help you decide whether an OTC device, a mid-range prescription model, or a premium combination instrument is the right fit, and whether the extra cost is clinically justified in your case. You can find a broader overview of evidence-based tinnitus treatments, including sound therapy and CBT, in our complete tinnitus treatments guide.

  • Cochlear Implants and Tinnitus: Who Qualifies and What the Evidence Shows

    Cochlear Implants and Tinnitus: Who Qualifies and What the Evidence Shows

    Cochlear Implants and Tinnitus: The Short Answer

    Cochlear implants can reduce tinnitus in the majority of eligible patients with severe-to-profound hearing loss, but eligibility is based on hearing criteria, not tinnitus severity. In a prospective cohort study of 323 patients, 90% of those with pre-existing tinnitus experienced improvement, with a 58% reduction in perceived loudness after cochlear implantation (Wang et al. (2024)). The implant is primarily a hearing restoration device; tinnitus relief is a well-documented secondary benefit. Tinnitus without qualifying hearing loss is not an approved indication and is classified as investigational by insurers.

    Could a Cochlear Implant Address Both Your Hearing and Your Tinnitus?

    If you have significant hearing loss alongside persistent tinnitus, you may be wondering whether a cochlear implant could address both problems at once. Or perhaps your tinnitus is the bigger issue, and you are asking whether it alone might qualify you.

    A cochlear implant is an electronic device that is surgically placed in the inner ear. Instead of amplifying sound like a hearing aid, it bypasses damaged cochlear hair cells and directly stimulates the auditory nerve with electrical signals. That distinction matters, because it is central to why the device also affects tinnitus.

    This article explains who qualifies for a cochlear implant based on current audiological criteria, what the evidence actually shows for three different patient groups, and what the honest risk-benefit picture looks like before you walk into a consultation. The goal is to help you have a more informed conversation with your ENT surgeon or audiologist.

    How a Cochlear Implant Can Affect Tinnitus: The Mechanism

    To understand why a cochlear implant can quiet tinnitus, it helps to understand what is thought to cause tinnitus in the first place when severe hearing loss is involved.

    When the cochlea sustains significant damage, the auditory cortex stops receiving the level of input it expects. In response, it compensates by increasing its own sensitivity, essentially turning up its internal gain. The result is amplified neural activity that the brain perceives as sound, even when no external sound is present. This is the central gain hypothesis, and it underlies most current thinking about tinnitus associated with hearing loss.

    A cochlear implant restores structured electrical stimulation to the auditory nerve. Think of the auditory cortex as a volume knob that cranks upward when the signal disappears. The implant turns the signal back on, and the brain’s compensatory amplification begins to subside.

    Research documents two time-scales for this effect. The first is rapid: many patients notice their tinnitus quieting within minutes of the device being switched on for the first time. The second is slower: tinnitus continues to improve over months as the auditory cortex adapts to the new stimulation pattern (Wang et al. (2024)). Tinnitus suppression appears to be a direct neural effect of the electrical stimulation, not simply a byproduct of hearing better.

    Who Qualifies for a Cochlear Implant? The Candidacy Criteria

    Eligibility for a cochlear implant is determined by audiological assessment, not by how severe or distressing your tinnitus is. There are three patient groups for whom criteria now exist, and they differ meaningfully.

    Group 1: Bilateral severe-to-profound sensorineural hearing loss (SNHL)

    This is the standard CI candidate. Sensorineural hearing loss means the damage is in the inner ear or auditory nerve rather than the middle ear. The typical threshold for consideration is a pure-tone average (PTA) of 70 dBHL or worse at 500, 1000, and 2000 Hz, with limited benefit from hearing aids (Blue Cross NC Coverage Policy). In the UK, NICE criteria specify sounds at 80 dBHL or worse at two or more frequencies, with aided speech scores at or below 50% (NICE Technology Appraisal TA566 (2019)). In practice, this means your hearing is severely reduced even with well-fitted hearing aids.

    Group 2: Single-sided deafness (SSD)

    Single-sided deafness means profound hearing loss in one ear with functional hearing in the other. The FDA approved cochlear implantation for SSD in January 2022 for patients aged 5 and older. The audiological criteria for the affected ear are a PTA above 80 dBHL and a word recognition score below 5% (Cochlear North America Clinical Recommendations (2024)). Insurers typically require a trial of a CROS hearing aid before approving CI for SSD.

    Group 3: Tinnitus as the primary indication without qualifying hearing loss

    This is not currently an approved indication. If your hearing loss does not meet the thresholds above, a cochlear implant for tinnitus relief is classified as investigational and is not covered by insurance in the US or reimbursed under NICE criteria in the UK (Blue Cross NC Coverage Policy).

    What the Evidence Shows by Patient Group

    Bilateral severe-to-profound hearing loss

    This is the most studied group, and the evidence is strong. In the largest and most recent prospective cohort study (n=323), 90% of patients with pre-existing tinnitus experienced improvement after cochlear implantation, with a 58% reduction in tinnitus loudness and a 44% reduction in Tinnitus Handicap Inventory (THI) scores. The THI is a validated questionnaire that measures how much tinnitus interferes with daily life. The effect size was d=1.4, indicating a large clinical impact (Wang et al. (2024)).

    A 2024 meta-analysis of 28 studies covering 853 patients found a mean THI reduction of 14.02 points post-implantation (Li et al. (2024)). An earlier meta-analysis of 27 studies and 1,285 patients found an even larger THI reduction of 23.2 points, alongside improvements in quality of life scores and reductions in anxiety and depression (Yuen et al. 2021, cited in Li et al. (2024)).

    Complete tinnitus resolution is not guaranteed. Across studies, complete abolition occurs in roughly 20 to 45% of patients, partial improvement in the majority, and a small percentage experience worsening. The Li et al. (2024) meta-analysis notes that the suppression effect may diminish over extended follow-up, a finding that is worth discussing with your surgeon.

    Single-sided deafness

    The evidence for SSD patients is equally strong, and the effect sizes are, if anything, larger. A systematic review of 13 studies covering 153 SSD patients found a combined improvement rate of 87.9%, with complete tinnitus suppression in 34.2% and further improvement in 53.7%. No cases of new tinnitus were reported in SSD patients following implantation (Peter et al. (2019)).

    A later meta-analysis of 17 studies and 247 SSD patients found an overall improvement rate of 89.4%, a THI reduction of 35.4 points (substantially larger than the bilateral SNHL group), and a VAS reduction of 4.6 points (Levy et al. (2020)).

    For direct comparison, only one randomised controlled trial exists. Wendrich et al. (2024) randomised 120 SSD patients to CI, a bone conduction device, a CROS hearing aid, or no treatment. At 24 months, only the CI group showed significant tinnitus reduction: THI decreased by a median of 23 points and VAS by 60 points. Neither CROS aids nor bone conduction devices produced meaningful tinnitus improvement. The effect was stable from three months onward.

    De novo tinnitus: the risk for those without pre-existing tinnitus

    Approximately 3 to 10% of people who had no tinnitus before surgery develop it after cochlear implantation. Wang et al. (2024), the largest prospective study, reported a rate of 3.4% (4 out of 112 previously tinnitus-free recipients). An earlier figure from a smaller series cited within Li et al. (2024) put the rate at 9.2%. In SSD patients specifically, Peter et al. (2019) reported zero cases of new tinnitus across 153 patients.

    The range across studies (3 to 12%) reflects differences in population, study design, and follow-up duration. More recent and larger studies tend to report lower rates, but this risk should be part of any pre-operative conversation.

    The Honest Risk-Benefit Picture: What to Discuss With Your Surgeon

    For patients who meet the audiological criteria and have pre-existing tinnitus, the balance of evidence is genuinely encouraging. The majority will experience meaningful tinnitus relief, and secondary outcomes also improve: Wang et al. (2024) documented statistically significant improvements in anxiety scores and sleep quality alongside tinnitus reduction. These are outcomes that matter day-to-day, not just on a questionnaire.

    The risks deserve equal attention, though:

    • De novo tinnitus develops in a small minority of previously tinnitus-free recipients (3.4% in the largest prospective study).
    • Residual hearing loss: electrode insertion carries a risk of cochlear trauma. If you have any remaining hearing in the implanted ear, it may be reduced or lost after surgery.
    • Cochlear implantation is not reversible. Once the electrode is inserted, returning to unaided hearing in that ear is not possible.
    • Outcomes are unpredictable at the individual level. No reliable pre-operative factors have been identified that predict how much tinnitus relief a given patient will experience.

    Before your consultation, ask your audiologist to include a formal tinnitus assessment alongside the standard hearing tests. Tools like the THI give you a baseline score to compare against post-operative outcomes. Make sure tinnitus relief, not just hearing improvement, is part of the goals you set together.

    Conclusion: Is a Cochlear Implant Right for You?

    Cochlear implants are not a tinnitus treatment in themselves, but tinnitus relief is a well-supported secondary benefit for the large majority of patients who meet hearing-loss criteria. Eligibility depends on audiological findings, not on how loud or distressing your tinnitus is.

    If you have severe-to-profound bilateral hearing loss or single-sided deafness alongside persistent tinnitus, the evidence gives genuine grounds for optimism, while making clear that complete resolution cannot be guaranteed and that a small risk of worsening exists.

    The most useful next step is to ask your ENT surgeon or audiologist for a formal cochlear implant evaluation and to put tinnitus outcomes explicitly on the agenda. You deserve to go into this decision with the full picture.

  • Can Hearing Aids Really Help Tinnitus? Evidence, Limits, and Best Options

    Can Hearing Aids Really Help Tinnitus? Evidence, Limits, and Best Options

    Hearing Aids for Tinnitus: The Short Answer

    Hearing aids are most likely to reduce tinnitus when co-existing hearing loss is present. In a randomised controlled trial of 114 patients with high-frequency sensorineural hearing loss, 71–74% achieved a clinically meaningful reduction in tinnitus distress within three months of wearing hearing aids (Yakunina et al. (2019)). For people with normal hearing, amplification is not recommended and carries a real risk of making symptoms worse. Whether hearing aids will help you depends almost entirely on whether hearing loss is part of your picture.

    The Promise and the Reality of Hearing Aids for Tinnitus

    With dozens of articles ranking the “best hearing aids for tinnitus” and audiologist websites promising relief, it is easy to come away thinking that hearing aids are a straightforward fix. They are not, or at least, not for everyone.

    If you are researching this because you are tired of the ringing and wondering whether a hearing aid is worth hundreds or thousands of dollars, your scepticism is well placed. The marketing often runs ahead of the evidence. Some clinics promote combination devices with built-in sound generators as a premium solution; the RCT data does not support the extra cost.

    This article skips the product rankings and focuses on what actually determines whether hearing aids help: your specific type of tinnitus and whether hearing loss is part of it. The evidence comes from randomised controlled trials and clinical guidelines, not manufacturer claims.

    Why Hearing Loss Is the Key Variable in Hearing Aids for Tinnitus

    To understand why hearing loss matters so much, it helps to know what researchers believe is happening in the brain when tinnitus develops.

    When the cochlea (the inner ear) is damaged by noise, age, or illness, it sends fewer signals up the auditory nerve. The brain responds by turning up its own internal sensitivity to compensate, a process researchers call central gain. This compensatory hyperactivity is thought to generate the phantom sound you perceive as tinnitus. A hearing aid restores the peripheral sound input that has been reduced, which in turn can dial down the brain’s over-amplified response.

    This mechanism only applies when hearing loss is genuinely driving the process. For someone with a normal audiogram, the brain is not compensating for missing input, so there is no peripheral deficit for a hearing aid to correct. Amplification in that situation does not address the underlying cause and, as the clinical guidelines make clear, may cause harm.

    Roughly 90% of people with chronic tinnitus have measurable co-existing hearing loss (Hearing Aids and Masking Devices for Tinnitus), which means the majority of tinnitus patients are at least potential candidates for amplification. The question is whether their individual profile makes them a good fit.

    What the Evidence Actually Shows

    The evidence on hearing aids for tinnitus sits across three tiers, and reading all three together gives the most accurate picture.

    RCT data: the best available outcomes

    Yakunina et al. (2019) conducted a double-blind randomised controlled trial with 114 patients who had high-frequency sensorineural hearing loss and chronic tinnitus. Participants wore hearing aids for three months, then stopped. At the three-month mark, 71–74% across all three device groups achieved a reduction of at least 20% on the Tinnitus Handicap Inventory (THI), a validated scale measuring how much tinnitus disrupts daily life. At six months (three months after discontinuing the devices), 52–59% maintained that level of improvement. Critically, all three amplification strategies performed equally well, and standard fitting was sufficient.

    A separate RCT by Henry et al. (2017) compared conventional hearing aids, combination instruments (hearing aid plus built-in sound generator), and extended-wear hearing aids in 55 patients. Average Tinnitus Functional Index scores improved by 21 points in the standard hearing aid group and 33 points in the combination group, but the difference was not statistically significant. The study’s own conclusion was that there is “insufficient evidence to conclude that any of these devices offers greater relief from tinnitus than any other one tested” (Henry et al. (2017)).

    Clinical guidelines: what they recommend

    The UK’s NICE guideline (NG155) sets out a three-tier framework: offer amplification to tinnitus patients whose hearing loss affects communication; consider it when hearing loss is present but communication is unaffected; and do not offer amplification to people with tinnitus but no hearing loss, with the explicit warning that “amplified sound may induce a hearing loss” (National (2020)).

    A systematic review comparing 10 clinical practice guidelines found that hearing aids were not unanimously recommended across guidelines, in contrast to counselling and CBT, which appeared in all of them (Meijers et al. (2023)).

    The Cochrane caveat

    The Cochrane systematic review by Sereda et al. (2018) pooled eight RCTs with 590 participants examining hearing aids, sound generators, and combination devices. Its conclusion is the most sobering in the evidence base: there is no trial data comparing any sound therapy device against a waiting list or placebo control. All comparisons are device against device. This means the within-group improvements seen in trials like Yakunina could partly reflect natural history or placebo effects rather than the device itself. The Cochrane review rated all evidence as low quality and concluded it “cannot support the superiority of any sound therapy option over another” (Sereda et al. (2018)).

    What this means in practice: the evidence is genuinely encouraging, particularly for patients with high-frequency hearing loss, but individual results vary and no definitive efficacy claim holds up against the most rigorous methodological standard.

    Who Is Most Likely to Benefit — and Who Isn’t

    Your likelihood of benefiting from a hearing aid depends substantially on which of three profiles fits you.

    Profile 1: Tinnitus with confirmed hearing loss (especially high-frequency)

    This is the group with the strongest evidence behind them. The Yakunina et al. (2019) RCT was specifically designed for patients with this profile, and the 71–74% response rate at three months is the most concrete outcome figure available. The benefits may extend beyond tinnitus itself: a prospective study by Zarenoe et al. (2017) found that patients with both tinnitus and hearing loss showed significantly greater improvements in working memory and sleep quality after hearing aid fitting than patients with hearing loss alone. If you are in this group and have not yet tried a properly fitted hearing aid, the evidence supports giving it a real trial.

    Profile 2: Tinnitus without measurable hearing loss

    Hearing aids are not recommended for this group. The NICE guideline is explicit: do not offer amplification devices to people with tinnitus but no hearing loss (National (2020)). The central gain mechanism that hearing aids address depends on peripheral hearing loss being present. Without it, there is no audiological deficit for the device to correct. For people who also have hyperacusis (increased sensitivity to sound), amplification carries an additional risk of worsening that sensitivity. If this is your profile, evidence-based options include cognitive behavioural therapy (CBT) and other neurologically focused approaches.

    Profile 3: Tinnitus with hearing loss, but standard hearing aids haven’t helped

    Combination instruments, devices that combine amplification with a built-in sound generator, are sometimes marketed as the next step. The Henry et al. (2017) RCT found numerically greater TFI improvement with combination devices (33 points versus 21 points for standard hearing aids), but the difference did not reach statistical significance in a trial of 55 participants. The study was likely underpowered to detect a true difference if one exists, but on current evidence, the added cost of a combination device is not clearly justified. Patients in this group should discuss the options with an audiologist who specialises in tinnitus, rather than assuming a more expensive device will deliver more relief.

    If you are in Profile 1 or Profile 3, the single most useful step is a formal audiological evaluation before any purchase decision.

    Features Worth Looking For — and Marketing Claims to Ignore

    If you have confirmed hearing loss and are considering a hearing aid, a few practical points are worth knowing before you visit a clinic or browse options.

    Open-fit or receiver-in-canal (RIC) styles avoid blocking the ear canal, which is relevant for tinnitus patients because occluding the canal can amplify the internal perception of the ringing. These styles allow natural sound to enter alongside amplified sound.

    Frequency-specific fitting calibrated to your audiogram is standard in any prescription device. The Yakunina et al. (2019) trial found that frequency-lowering strategies offered no additional tinnitus benefit over conventional fitting, so there is no evidence basis for paying a premium for specialist frequency-shifting algorithms marketed for tinnitus.

    Bluetooth streaming capability is useful for connecting hearing aids to sound therapy apps, which some patients find helpful as a complement to amplification.

    Built-in tinnitus masking programmes are a legitimate add-on feature, and many prescription devices include them. The evidence does not show they outperform amplification alone (Sereda et al. (2018)), but they do no harm and some patients find them useful for specific situations, like quiet environments at night.

    On OTC versus prescription: over-the-counter hearing aids are more affordable and now available in the US following FDA regulatory changes in 2022, but they require self-fitting. For tinnitus management specifically, audiologist-fitted devices calibrated to your individual audiogram are preferable. Self-fitting is unlikely to adequately address the specific frequency profile that drives your particular tinnitus.

    Conclusion: The Bottom Line on Hearing Aids for Tinnitus

    Hearing aids are among the better-supported practical interventions for tinnitus, but the evidence applies specifically to people with co-existing hearing loss, and the realistic outcome is reduced distress, not silence.

    If you have tinnitus and have never had a formal hearing test, that is the right first step. If hearing loss is confirmed, a properly fitted hearing aid has meaningful RCT evidence behind it and is a reasonable first-line option. If your hearing tests as normal, amplification is not the answer and could make things worse. CBT and other approaches have stronger support for your profile.

    A good audiologist will tell you honestly whether a hearing aid makes sense for your situation. If your hearing is normal and they still want to sell you a device, that is a signal to seek a second opinion.

  • Progressive Tinnitus Management: The VA’s Step-by-Step Stepped-Care Protocol

    Progressive Tinnitus Management: The VA’s Step-by-Step Stepped-Care Protocol

    What Is Progressive Tinnitus Management?

    Progressive Tinnitus Management (PTM) is the VA’s five-level stepped-care protocol for tinnitus: most patients’ needs are met at Level 3, which involves five structured sessions combining sound therapy guidance from an audiologist and brief CBT from a mental health provider, with Levels 4 and 5 reserved for the minority whose tinnitus remains bothersome after that. Developed by VA’s National Center for Rehabilitative Auditory Research (NCRAR), PTM is the VA’s flagship tinnitus care program serving roughly 2 million veterans with service-connected tinnitus. The model’s defining feature is matching intervention intensity to patient need rather than applying the same high-intensity treatment to everyone from the start.

    Why a Stepped Protocol — and Who It’s For

    If a provider has referred you to Progressive Tinnitus Management, your first reaction might be something like: “A five-level program? For ringing in my ears?” That reaction is completely understandable. A structured, multi-step protocol can sound over-medicalised for something that, from the outside, looks like a single symptom.

    The case for PTM’s structure is actually about efficiency, not complexity. The protocol is built on a simple idea: most people with tinnitus don’t need intensive individualised treatment. They need good information, a practical sound strategy, and a small set of coping skills. PTM delivers exactly that at Level 3 and then stops. The more intensive levels exist only for the minority who genuinely need them.

    This article covers all five levels in plain language, from the patient’s point of view. It also closes with a section for non-veterans and civilians who encounter this protocol in research or through a provider referral and want to know whether it applies to them.

    The Five Levels of PTM: A Patient-Facing Walkthrough

    PTM’s five levels are not five rungs of severity that everyone climbs. Think of them instead as five decision points. You move to the next level only if your tinnitus is still meaningfully bothering you after completing the current one. For most people, the journey ends at Level 3.

    Level 1: The Initial Referral

    Level 1 is not a treatment session. It is the point at which any clinician — a GP, a VA primary care provider, a nurse — recognises that a patient has bothersome tinnitus and refers them for audiological evaluation. The clinical task here is triage: is this person’s tinnitus causing enough distress to warrant a structured assessment? If yes, they move to Level 2.

    What completing this level looks like: a referral to audiology is placed. Nothing more is required from you yet.

    Level 2: Audiological Evaluation

    At Level 2, you meet with an audiologist for a hearing evaluation and a brief tinnitus assessment. The audiologist checks whether there is an underlying hearing loss, which is present in the majority of people with chronic tinnitus, and collects information about how your tinnitus is affecting daily life. This is also where validated outcome tools such as the Tinnitus Functional Index (TFI) or Tinnitus Handicap Inventory (THI) may be used for the first time to establish a baseline.

    If the assessment shows that your tinnitus is causing moderate or significant distress, you are offered Level 3. If your needs are straightforward and a brief audiological consultation answers your key questions, you may not need to go further.

    What completing this level looks like: you have a clear picture of your hearing, a baseline tinnitus severity score, and either a management plan or a referral to Level 3.

    Level 3: Skills Education Workshops (Where Most People’s Needs Are Met)

    Level 3 is the clinical core of PTM. It consists of five structured sessions delivered by two providers: two sessions with an audiologist and three with a mental health provider (typically a psychologist). Together, these sessions give you a practical sound management strategy and a set of CBT-derived coping tools.

    Although group delivery is the standard format, individual sessions are available where group delivery is not practical. The Tele-PTM format delivers all five sessions by telephone or video, removing geographic barriers entirely.

    At the end of Level 3, your TFI or THI score is reviewed again. If your tinnitus distress has fallen into the mild range (TFI below 32 is generally used as the threshold indicating a minimal-to-mild problem), your care is complete. The majority of patients who engage with PTM do not need to go further.

    What completing this level looks like: you have a personal sound plan, a set of practised coping skills, and a re-scored outcome measure showing whether your distress has meaningfully reduced.

    Level 4: Interdisciplinary Evaluation

    A minority of patients finish Level 3 and still find their tinnitus significantly bothersome. Level 4 is the point at which a more thorough, interdisciplinary evaluation takes place, involving both audiology and mental health. The goal is to understand specifically what is maintaining the distress: Is it an unaddressed hearing loss? Anxiety or depression interacting with tinnitus perception? Sleep disruption? The evaluation shapes a tailored plan for Level 5.

    Reaching Level 4 does not mean Level 3 failed. It means the protocol is working exactly as designed: identifying the people who need more, and providing it.

    Level 5: Individualised Treatment

    Level 5 is one-on-one, personalised support building directly on the foundation of Level 3 skills. Sessions are tailored to what the interdisciplinary evaluation identified. This may include more intensive cognitive restructuring, hearing aid fitting or optimisation, or, where sleep disruption is a major factor, additional support for insomnia. The dossier notes that CBT specific to insomnia has been discussed at this level, though the evidence for that specific application within PTM is less well established than the general CBT evidence base.

    What completing this level looks like: an individualised care plan that continues as long as clinically warranted.

    What Happens in Level 3: The Core Skills Education Sessions

    Level 3 is where the practical work of PTM happens, so it is worth describing in detail.

    The two audiologist-led sessions focus on therapeutic sound use. The audiologist explains why sound enrichment helps tinnitus: background sound reduces the contrast between the tinnitus signal and a silent environment, making the tinnitus less attention-grabbing. You work together to build a personal sound plan, which identifies specific types and sources of sound that work for you in the situations where tinnitus is most intrusive — at night, during focused work, in quiet meetings. The plan is written down and practical, not theoretical.

    The three mental health sessions are led by a psychologist and draw directly on CBT principles. Session content includes attention management (techniques for deliberately redirecting attention away from the tinnitus signal), cognitive restructuring (identifying and challenging catastrophising thoughts such as “this will ruin my life” or “I will never sleep properly again”), and relaxation strategies to reduce the physiological arousal that amplifies tinnitus perception. Session structure across the three appointments is progressive: the first session establishes the CBT framework, the second and third sessions build and practise skills.

    The CBT component of Level 3 reflects a strong, independent evidence base. A Cochrane review of 28 randomised controlled trials involving 2,733 participants found that CBT reduces tinnitus impact on quality of life by a margin exceeding the minimum clinically important difference on the THI (Fuller et al., 2020).

    At the end of Level 3, the TFI is re-administered. A score above 32 (the threshold for a moderate problem by established TFI severity categories) is the clinical signal that the patient may benefit from progression to Level 4. A score below that threshold generally indicates that care at this level has been sufficient.

    A large RCT across VA clinics in Memphis and West Haven randomised 300 veterans to PTM Level 3 workshops or a six-month waitlist control. Both sites showed statistically significant TFI improvements, with a combined effect size of 0.36 (Henry et al., 2017). Telephone delivery produced comparable results: a separate RCT of 205 participants found that Tele-PTM produced a high effect size on the TFI compared to waitlist control (Henry et al., 2019).

    Real-world uptake data from virtual PTM cohorts in 2022 to 2024 found that 93% of veterans who completed the programme would recommend it to others, and 60 to 68% reported meaningful improvements in tinnitus botheringness, coping ability, and sense of control.

    Evidence Base: What the Research Shows

    Two published RCTs form the core of PTM’s evidence base.

    The first, conducted at VA medical centres in Memphis and West Haven, randomised 300 veterans to the five-session PTM Level 3 workshops or a six-month waitlist. The PTM group showed statistically significant reductions in TFI scores at both sites, with a combined effect size of 0.36 (Henry et al., 2017). Effect sizes in this range are considered clinically meaningful in tinnitus research, where the symptom is subjective and self-reported.

    The second RCT evaluated telephone-delivered PTM in 205 participants, including people with traumatic brain injury (TBI), recruited from across the US. Tele-PTM produced a high effect size on the TFI compared to the waitlist control, with improvements also observed on anxiety and depression scales (Henry et al., 2019). Results were consistent across TBI severity categories, broadening the population for whom the approach appears suitable.

    PTM’s CBT component is independently supported by the highest-quality evidence in tinnitus research. A Cochrane systematic review of 28 RCTs (N=2,733) found that CBT significantly reduced tinnitus impact on quality of life, with THI reductions exceeding the minimum clinically important difference (Fuller et al., 2020).

    Three honest caveats are worth noting. First, both PTM RCTs were conducted in predominantly male veteran populations with noise-induced tinnitus; how well results generalise to more heterogeneous civilian groups is a reasonable question, though the Tele-PTM trial did accept non-VA participants from across the US. Second, the TFI threshold used as a clinical decision trigger for progression (a score above 32) is a clinical convention based on established severity categories, not a formally validated decision rule from a separate study. Third, implementation evidence shows that full PTM, with all five Level 3 sessions delivered by both an audiologist and a mental health provider, is rarely delivered in practice at most VA facilities. A national survey of 153 clinicians across 144 VA facilities found that few offered complete PTM, with audiology-mental health collaboration the primary structural barrier (Zaugg et al., 2020).

    For patients, this means that ‘receiving PTM’ may mean different things at different facilities. Asking your provider specifically which sessions are offered and by which disciplines is a reasonable and useful question.

    Not a Veteran? How to Apply the PTM Logic to Your Own Care

    PTM as a formal protocol requires VA or DoD access. The workbook, however, is freely available on the NCRAR website (‘How to Manage Your Tinnitus: A Step-by-Step Workbook’) and can be used by anyone as a self-directed companion to clinical care.

    More broadly, the logic underlying PTM maps directly onto civilian care pathways. You do not need a VA card to benefit from the same stepped approach.

    Here is how the levels translate for civilian readers:

    Your GP or primary care provider is a natural Level 1. A conversation about tinnitus botheringness and a referral to audiology is all this step requires. Most GPs can do this; the barrier is usually knowing to ask.

    Audiological assessment is available privately and through NHS or public health systems. This is the civilian equivalent of Level 2: establishing a hearing baseline and a tinnitus severity score.

    For Level 3 skills, online CBT programmes are a validated alternative. A 2024 meta-analysis of 14 RCTs covering 1,574 patients found that internet-based therapies (the majority of which were CBT-based) reduced TFI scores by an average of 24.56 points (Cohen’s d=0.80, a large effect) compared to minimal change in control groups (Sia et al., 2024). That is a clinically substantial reduction, and it is achievable without specialist access.

    If you are still significantly bothered after completing a CBT-based programme, ask your audiologist or GP for a referral to a tinnitus specialist or hearing therapist. That is the civilian equivalent of Levels 4 and 5: escalating to individualised support for those who need it.

    The underlying principle is the same whether you are in a VA clinic or a private audiology practice: start with education and structured skills, and escalate only if you genuinely need more.

    The Bottom Line

    Progressive Tinnitus Management is not a demanding five-level marathon. For most people, it is a five-session skills programme that provides practical tools for managing tinnitus in daily life, and then it ends. The structure exists to make sure that the minority who need more intensive support can access it without everyone else having to go through it.

    Whether you are a veteran with VA access or a civilian working through the public or private healthcare system, the first concrete step is the same: an audiological assessment to understand your hearing, establish a baseline severity score, and map out the most appropriate next step. From there, the path becomes considerably clearer.

    For a broader overview of the treatments that PTM draws on, including sound therapy, CBT, and hearing aids, see our guide to evidence-based tinnitus treatments. If sleep is your primary concern, the article on CBT for tinnitus-related sleep problems covers that specific application in more detail.

  • Headphones and Tinnitus: Safe Volume, Best Types, and What to Avoid

    Headphones and Tinnitus: Safe Volume, Best Types, and What to Avoid

    Why Headphones Feel Risky When You Have Tinnitus

    If you have stopped using headphones because you are afraid of making your tinnitus worse, you are not alone. Many people with tinnitus describe the same fear: putting on a pair of headphones (even quietly) and feeling their tinnitus suddenly louder and more intrusive. For some, this leads to abandoning headphones entirely, which means losing music on a commute, struggling with audio calls from home, or cutting out podcasts that used to make a long day easier. That disruption is real and it matters.

    The reassurance is this: there are two separate things that can go wrong with headphones, and only one of them is a genuine danger. The first is noise-induced cochlear damage from listening too loudly for too long, which can worsen underlying hearing loss over time. The second is a temporary salience effect: blocking your ears or creating a quiet environment makes tinnitus feel louder simply because there is less ambient sound to mask it. That second effect is uncomfortable, but it does not cause any physical harm. Understanding which of these you are dealing with changes everything about how you approach headphone use.

    What Actually Happens in Your Ears With Tinnitus Headphones

    Your cochlea contains thousands of tiny hair cells that convert sound waves into electrical signals. Loud noise physically damages these cells, and they do not grow back. About 90% of tinnitus cases involve some degree of noise-induced hearing loss (American Tinnitus Association, Preventing Noise-Induced Tinnitus). When hair cells are lost, the brain compensates by turning up its internal gain, amplifying signals from the auditory pathway to make up for the reduced peripheral input. That amplified signal, with no external source, is what you hear as tinnitus (American).

    At moderate volumes, headphone use does not damage hair cells and does not trigger this process further. The risk is not headphones; it is volume combined with duration. Research on personal audio devices found that listening at 100% volume through standard earbuds produces sound levels around 97 dB at the eardrum, causing measurable temporary threshold shifts in just 30 minutes. At 75% volume, the same device measured around 83 dB, with no significant changes to hearing thresholds. At 50%, it measured around 65 dB, well within the safe range (Gopal et al., 2019).

    No peer-reviewed trial has specifically studied whether habitual headphone use worsens existing tinnitus severity in people who already have the condition. What clinical guidance is based on is the well-established principle that only excessive volume causes cochlear damage, and that principle applies to people with tinnitus just as it does to everyone else.

    Safe Volume: The Numbers You Actually Need

    The 60/60 rule (keep volume below 60% and listen for no more than 60 minutes at a time) is a useful starting point, but it is a heuristic, not a clinical standard. Sixty percent volume on one device produces a different decibel level than 60% on another.

    For a more grounded picture, the WHO and NIDCD provide specific thresholds:

    Volume levelApprox. dBSafe exposure time
    Background listening70 dB or belowIndefinitely safe
    Moderate listening80 dBUp to 40 hours/week (WHO, 2019)
    Elevated listening85 dBUp to 8 hours/day (NIDCD, 2020)
    Loud listening100 dB15 minutes maximum per day
    Maximum device volume94–110 dBDamaging within minutes

    One figure is worth holding onto: reducing your volume by just 3 dB halves your cumulative cochlear exposure (World, 2019). Turning down from 80% to somewhere around 70% makes a measurable difference over time.

    Both iOS and Android now include hearing health features worth switching on. Apple’s Health app tracks headphone audio levels and alerts you when weekly exposure approaches the WHO limit. Android’s ‘volume warning’ feature prompts you when you go above a threshold. These are not perfect, but they add a useful check against gradual volume creep, especially in noisy environments where you might not notice you have pushed the volume up.

    If you have existing hearing loss alongside tinnitus, your threshold for damage may be lower than the standard figures suggest. Ask your audiologist about the right volume ceiling for your hearing profile.

    Which Headphone Type Is Safest If You Have Tinnitus

    Not all headphones deliver sound the same way, and the design matters both for how much cochlear pressure sound creates and for how your tinnitus feels during use.

    In-ear earbuds sit directly in the ear canal, creating a sealed acoustic environment. This design delivers higher direct pressure to the eardrum at equivalent volume settings compared to other types. They also produce the strongest occlusion effect: blocking the ear canal reduces ambient sound masking and can make tinnitus feel noticeably more prominent even at low volumes. For people with tinnitus, in-ear earbuds are the least comfortable design.

    Over-ear closed-back headphones sit around the ear rather than in the canal. Their passive isolation reduces background noise, which means you are less tempted to raise volume to compete with your environment. The trade-off is the same occlusion effect that earbuds produce, though typically less intense.

    Over-ear open-back headphones have perforated or mesh ear cups that allow ambient sound to pass through. This bleed of environmental sound reduces the isolation effect that makes tinnitus feel louder, and it keeps the acoustic environment more natural. Open-back designs are often recommended by audiologists specifically for tinnitus patients who find occlusion distressing (American Tinnitus Association).

    Bone conduction headphones transmit sound through the cheekbones rather than through the ear canal, which means they do not occlude the ear. Many people with tinnitus find them comfortable for this reason. The important caveat: bone conduction still delivers vibration directly to the cochlea. At high volumes, the cochlear exposure is equivalent to conventional headphones. Bone conduction is not a free pass to listen loudly.

    For most people with tinnitus, over-ear headphones with good noise isolation, used with noise cancellation switched on during audio playback, represent the most practical combination: passive isolation reduces the need to raise volume, and ANC further cuts ambient intrusion.

    The Noise-Cancelling Paradox: When ANC Makes Tinnitus Feel Louder

    Active noise cancellation is genuinely useful for protecting hearing. ANC headphone users, on average, listen at lower volumes than people using standard headphones, because they are not competing with background noise (American). The benefit is real.

    The paradox is this: wearing ANC headphones with no audio playing creates an unusually quiet acoustic environment, and in that silence, tinnitus becomes more salient. The brain is always listening. In ambient noise, the tinnitus signal is partially masked. Remove that masking and the same tinnitus, at the same underlying level, feels louder and more intrusive. This is a perception effect, not physical damage. Wearing ANC headphones in silence does not cause any additional cochlear harm.

    Audiologists advise against using ANC headphones as makeshift ear defenders in silence for this reason. If you put on noise-cancelling headphones and your tinnitus immediately seems to fill the space, that is the salience effect. The solution is simple: pair the ANC with low-level audio. Even quiet music, a podcast at comfortable volume, or a nature sound track uses the masking effect constructively, reducing tinnitus salience while the ANC keeps you from needing to push the volume higher to compete with environmental noise.

    Using ANC as a tool for listening, not as a tool for silence, is the practical takeaway here.

    What to Avoid — and When to Take a Break

    Some specific scenarios carry real risk or real discomfort for people with tinnitus:

    • In-ear earbuds at high volume. The combination of direct canal exposure and high dB output is the highest-risk scenario for cochlear damage.
    • Listening above 85 dB for extended periods. At this level, hair cell fatigue accumulates and, with repeated exposure, can cause permanent damage (American).
    • Volume creep in noisy environments. On a commute or in a café, it is easy to push volume up without noticing. This is the scenario ANC headphones are designed to prevent.
    • ANC headphones worn in silence. As described above, this increases tinnitus salience without any protective benefit.
    • Listening during a tinnitus spike. When your tinnitus flares (whether from stress, sleep deprivation, or a noisy day) your auditory system is already in a heightened state. Taking a break from all headphone use during a spike gives the auditory system time to settle. This is a temporary measure, not a permanent change.
    • Prolonged sessions without breaks. Even at moderate volumes, taking a break every hour reduces the cumulative load on the auditory system (American).

    Avoidance should be a short-term response during flares, not a long-term strategy. Cutting out headphones permanently is not necessary, and it removes a genuinely useful tool for sound enrichment and tinnitus masking.

    You Don’t Have to Choose Between Tinnitus and Your Headphones

    The fear that any headphone use will permanently worsen tinnitus is understandable, and it stops many people from using a tool that can actually help them manage their day. The evidence points in a more reassuring direction: it is volume and duration that damage the cochlea, not the act of putting on headphones.

    Keep volume at or below 70% as a working ceiling. Choose over-ear designs over in-ear earbuds. If you use noise-cancelling headphones, pair them with audio rather than silence. Take breaks during long listening sessions, and step away from headphones entirely during a tinnitus spike. Your audiologist can help you tailor these guidelines to your specific hearing profile.

    Headphones, used thoughtfully, can be part of daily life with tinnitus rather than a threat to it. For people who find that sound helps during difficult periods, they can even be part of managing it.

  • Tinnitus in Older Adults: Managing With Age-Related Hearing Changes

    Tinnitus in Older Adults: Managing With Age-Related Hearing Changes

    When Ringing Ears Feel Like One More Thing to Deal With

    About 1 in 5 older adults has tinnitus, and when it coexists with age-related hearing loss, fitting hearing aids is the single most impactful first step. A large population study found that hearing impairment roughly doubles the odds of tinnitus (OR 2.27), and evidence shows that hearing aids reduce tinnitus burden, improve sleep quality, and may help protect cognitive function (Oosterloo et al. (2021)). If you are an older adult dealing with tinnitus, or supporting someone who is, the good news is that practical, evidence-backed steps exist.

    When Ringing Ears Feel Like One More Thing to Deal With

    Tinnitus arrives for many older adults at a time when life already feels noisier with health concerns: a hearing test that didn’t go quite as hoped, nights that are harder to get through, and conversations that take more effort than they used to. A persistent ringing or buzzing on top of all that can feel overwhelming, and it is completely understandable if it does.

    What this article addresses is what makes managing tinnitus in later life different from managing it at 40 — the specific challenges that standard advice tends to skip over, the evidence behind hearing aids as more than a hearing device, and the practical steps that are most likely to make a real difference for this age group.

    Why Tinnitus Is More Common — But Not Inevitable — in Older Adults

    The most common reason tinnitus develops in older adults is age-related hearing loss, also called presbycusis. Over time, the tiny hair cells in the inner ear that convert sound waves into electrical signals gradually deteriorate. As the auditory signal reaching the brain weakens, the brain compensates by turning up its own internal sensitivity — a process researchers call central gain. The result can be phantom sounds: ringing, buzzing, or hissing that has no external source.

    A large Rotterdam Study of 6,098 older adults found that roughly 1 in 5 (21.4%) had tinnitus, and that having measurable hearing loss more than doubled the odds of experiencing it (OR 2.27) (Oosterloo et al. (2021)). Cardiovascular changes that come with age — reduced blood flow to the inner ear — and exposure to certain medications can also play a role, as discussed below.

    Here is the part that surprises many people: in the same study, tinnitus prevalence was roughly flat across different age groups within the older adult population, despite the fact that hearing loss increases steadily with age. Tinnitus is closely associated with ageing, but it is not simply an inevitable consequence of getting older (Oosterloo et al. (2021)). That distinction matters: it means there are factors you can address, rather than just a clock you cannot stop.

    Some causes are reversible. A build-up of earwax is a common and easily treated contributor — a GP or nurse can clear it quickly. Some medications can cause or worsen tinnitus (more on this below), and adjusting them under medical supervision sometimes reduces symptoms. Other contributors, like the gradual loss of cochlear hair cells, are not reversible, but the tinnitus that results from them is still very manageable.

    Tinnitus is common in older adults, but not inevitable. Hearing loss roughly doubles the risk — and some causes, such as earwax build-up or certain medications, are reversible.

    The Extra Challenges Older Adults Face

    General tinnitus advice — reduce stress, try white noise at night, see a specialist — is reasonable, but it does not capture three specific challenges that make tinnitus harder to manage in later life.

    Polypharmacy and ototoxic medications

    Many older adults take several medications simultaneously, and a significant number of commonly prescribed drugs can affect hearing or worsen tinnitus. A large US study (the Beaver Dam Offspring Study) found that 84 to 91% of older adults were taking at least one medication with ototoxic potential — among them, NSAIDs (such as ibuprofen and aspirin) taken by around 75%, and loop diuretics by around 35.6% of participants. Certain antibiotics (particularly aminoglycosides) and some chemotherapy agents also carry ototoxic risk.

    This does not mean these medications should be stopped. Many are prescribed for serious conditions, and the benefits will often outweigh the risk. The practical step is to raise the question with your GP: ask whether any current medications could be contributing to your tinnitus, and whether alternatives exist. Framing it as a medication review question — rather than asking to stop any particular drug — is usually the most productive approach.

    Never stop or reduce a prescribed medication because of tinnitus without speaking to your GP first. Some ototoxic medications treat conditions where stopping suddenly carries serious health risks.

    Sleep disruption

    Sleep quality tends to become more fragile with age regardless of tinnitus. Add a persistent ringing to already-lighter sleep architecture, and the effect compounds quickly. A meta-analysis of seven studies involving more than 3,000 tinnitus patients found that roughly 53.5% experienced sleep impairment (Gu et al. (2022)). While that figure covers adults of all ages and the study had high variability across its samples, objective data from the Rotterdam cohort specifically in older adults confirmed the relationship: tinnitus was independently associated with longer sleep onset latency, and in people with both tinnitus and hearing loss, circadian rhythm stability was also affected (de et al. (2023)).

    The quiet of the bedroom amplifies tinnitus perception, making it harder to fall asleep. Practical measures — keeping a low background sound playing overnight, maintaining a consistent sleep schedule, and avoiding complete silence at bedtime — can reduce how much the sound intrudes at the moment it matters most.

    Social withdrawal and isolation

    When hearing difficulty and tinnitus combine, social situations become genuinely exhausting. Following a conversation in a noisy room requires enormous effort; tinnitus adds an unwanted layer of sound that competes with speech. Over time, many people quietly reduce how often they socialise — fewer gatherings, less television, sometimes separate sleeping arrangements. These adaptations make sense in the short term, but sustained social withdrawal carries its own risks.

    Some research suggests that the combination of hearing loss, tinnitus, and the social isolation they can produce is associated with increased cognitive load and may contribute to accelerated cognitive decline in older adults (Jafari et al. (2019)). The connection is not fully established — longitudinal studies are still needed to confirm the causal direction — but it is a meaningful reason to treat tinnitus and hearing loss actively rather than simply accepting them.

    Hearing Aids: Not Just for Hearing

    For older adults who have both tinnitus and age-related hearing loss, hearing aids are the most evidence-backed intervention available — and they work on multiple levels, not just amplification.

    By restoring auditory input, hearing aids reduce the brain’s compensatory over-amplification that contributes to tinnitus. The resulting sound enrichment makes tinnitus less salient in everyday life: when there is more genuine sound to process, the phantom sound fades into the background. Many current hearing aid models also include built-in tinnitus masking features — programmable sounds that provide additional relief, particularly at night or in quiet environments.

    A prospective study of 100 patients fitted with hearing aids found that the group with both tinnitus and hearing loss showed significantly larger improvements than the hearing-loss-only group in two specific areas: working memory (assessed via Reading Span test, p less than 0.001) and sleep quality (assessed via the Pittsburgh Sleep Quality Index, p less than 0.001) (Zarenoe et al. (2017)). These were not marginal gains. Tinnitus severity scores also improved significantly at follow-up compared with baseline.

    There is also a broader cognitive health angle. Some research suggests that treating hearing loss with hearing aids may help reduce cognitive decline, particularly in people at higher baseline risk (Jafari et al. (2019)). A secondary analysis of a large US trial (ACHIEVE 2025) found that hearing aid use was associated with 62% slower cognitive decline in the highest-risk quartile of participants. This was a post-hoc subgroup analysis, so it should not be taken as definitive — but it points in a consistent direction, and a systematic review found that auditory amplification can improve cognition and quality of life alongside tinnitus burden (Malesci et al. (2021)).

    The referral path for hearing aids in the UK runs through your GP or directly to an NHS audiology service. A hearing assessment is the starting point. Private audiology clinics are also widely available for those who prefer faster access. If you are supporting an older relative who resists hearing aids because of stigma or cost concerns, the dual-benefit evidence — sleep, cognition, and tinnitus relief alongside better hearing — is worth sharing. Modern aids are considerably smaller and less conspicuous than older designs.

    One of the things patients with both tinnitus and hearing loss often say after being fitted with hearing aids is that they had not realised how much the combination was affecting their sleep and concentration. The improvement in tinnitus can feel like a side effect — a welcome one.

    Other Management Approaches That Work for Older Adults

    Hearing aids are the most evidence-backed starting point when hearing loss is present, but they are not the only option — and not every older adult with tinnitus has significant hearing loss.

    Sound enrichment at home

    Tabletop white noise machines, a radio playing softly at low volume, or smartphone apps that generate ambient sound (rain, a fan, nature sounds) can all reduce tinnitus salience — particularly at night. The principle is the same as with hearing aids: providing background sound makes the phantom noise less dominant. This is a low-barrier first step for anyone not yet fitted with hearing aids or waiting for an audiology appointment. The Cochrane review on sound therapy found clinically meaningful within-group improvements in tinnitus severity for people using amplification and sound enrichment devices, though it could not establish superiority over other active interventions (Sereda et al. (2018)).

    Cognitive behavioural therapy and TRT

    Cognitive behavioural therapy (CBT) is well-established for reducing tinnitus distress and is recommended in clinical guidelines. CBT does not reduce the volume of tinnitus, but it addresses the distress and the habitual attention that makes tinnitus disruptive. Evidence supporting CBT for tinnitus generally is solid, though age-specific trials are limited. CBT adapted for older adults can be delivered in-person or digitally, making it accessible to those with mobility constraints or limited travel options. Tinnitus Retraining Therapy (TRT) combines sound therapy with structured counselling and is also available through specialist audiology services in many areas.

    Access to these therapies varies by region. In England, a GP referral to an ENT or audiology service is typically the pathway to both.

    Cardiovascular and general health management

    Because reduced blood flow to the inner ear is a contributing factor in some age-related tinnitus, managing cardiovascular risk factors — blood pressure, exercise, diet — is a relevant background step. These are changes most older adults are already advised to make for other reasons; the tinnitus angle is simply one more reason they matter.

    Addressing sleep directly

    If sleep is significantly disrupted, treating that problem directly — rather than waiting for tinnitus to improve first — can break a reinforcing cycle. Avoiding complete silence at bedtime, maintaining consistent sleep and wake times, and limiting screen use before sleep are practical first steps. If sleep problems are severe, a GP can assess whether a sleep-specific referral is warranted.

    When to See a Doctor: Red Flags and Referral Paths

    Most tinnitus in older adults does not represent a medical emergency, but some presentations require prompt attention.

    Seek urgent help the same day or within 24 hours if:

    • Tinnitus has come on suddenly alongside a sudden drop in hearing (within the last 30 days)
    • You notice any sudden change in facial sensation or movement alongside tinnitus

    See your GP within one to two weeks if:

    • Tinnitus is getting rapidly worse
    • It is causing significant distress that affects daily activities

    Arrange a routine GP appointment if:

    • Tinnitus is in one ear only
    • Tinnitus is pulsatile (beating in time with your heartbeat)
    • Tinnitus is persistent and new, especially with no obvious cause

    All of these thresholds are consistent with NICE clinical guideline NG155, which recommends audiological assessment for all patients presenting with tinnitus (National (2020)).

    For any older adult with new tinnitus, a hearing test is a sensible baseline step even if the tinnitus feels mild. It establishes whether hearing loss is present and whether hearing aids would help. The usual pathway in the UK is GP to audiology or ENT, and NHS audiology departments can assess and fit aids without a specialist referral in many areas.

    Research suggests that older women in particular may be less likely to have tinnitus investigated, so if you feel your concerns have been dismissed, it is worth being direct with your GP about requesting a hearing assessment and onward referral.

    Tinnitus in Later Life Is Manageable — Start With Your Hearing

    Tinnitus is common in older adults, but it is not something you simply have to accept without support. Hearing loss is the most actionable risk factor: addressing it with hearing aids can reduce tinnitus burden, improve sleep, and may support cognitive health over time. Sound enrichment, CBT-based approaches, and a medication review with your GP round out a practical set of tools that go well beyond simply putting up with the noise.

    If you are not sure where to start, a conversation with your GP and a hearing assessment are the two most concrete steps you can take today. From there, the right combination of support can be shaped around what matters most to you.

  • Why Are My Ears Ringing? Common Causes Explained

    Why Are My Ears Ringing? Common Causes Explained

    That Ringing in Your Ears Has a Name — and Usually an Explanation

    Suddenly noticing a ringing, buzzing, or hissing sound in your ears — especially when it won’t stop — can be unsettling. You are not alone: tinnitus affects roughly 14.4% of adults globally, making it one of the most common auditory complaints people bring to their doctor (Jarach et al., 2022). For most people, there is a clear, identifiable cause. This article explains the most common causes, helps you understand what your specific experience might indicate, and makes clear when a GP visit is the right next step.

    So Why Are Your Ears Ringing?

    In most cases, ringing ears trace back to some disruption of the tiny sensory hair cells inside your inner ear. These cells convert sound vibrations into electrical signals that travel to your brain. When they are damaged or reduced in number, the brain no longer receives the input it expects — and it compensates by increasing its own internal activity. That internally generated noise is what you hear as ringing, buzzing, or hissing.

    The most common trigger is noise exposure: a loud concert, power tools, or earphones turned up too high. Age-related hearing loss runs a close second. Both gradually deplete hair cell function over time. Less commonly, earwax blockage, certain medications, or underlying health conditions are responsible.

    Tinnitus is most often caused by inner ear hair cell disruption from noise or age-related hearing loss. It is extremely common and, in many cases, either self-resolving or manageable with the right support.

    The Most Common Causes of Ear Ringing

    Rather than listing causes in isolation, it helps to group them by what they typically mean for you — and what to do next.

    Group 1: Temporary and likely self-resolving

    These causes usually produce short-lived tinnitus that fades once the trigger is removed.

    Noise exposure (temporary threshold shift): Leaving a concert or noisy venue with ringing ears is extremely common. The hair cells have been overstimulated but not permanently damaged — the ringing typically fades within hours. If it persists beyond 48 hours, the situation changes (more on this below).

    Earwax blockage: A build-up of earwax pressing against the eardrum can produce ringing or muffled hearing. Once the wax is removed professionally, the tinnitus usually resolves.

    Ear infection or fluid: Middle ear infections and fluid behind the eardrum alter how sound pressure reaches the inner ear, sometimes causing temporary ringing. Treating the infection typically resolves the symptom.

    Stress and fatigue: Heightened stress can increase awareness of bodily sounds, including low-level tinnitus that might otherwise go unnoticed. Sleep deprivation makes this worse. Addressing the underlying stress tends to reduce the perception.

    Group 2: Ongoing but manageable

    These causes tend to produce tinnitus that persists, but many respond well to management strategies.

    Age-related hearing loss (presbycusis): Gradual hair cell loss over decades is the most common cause of chronic tinnitus in older adults (Jarach et al., 2022). Hearing aids often reduce tinnitus perception alongside improving hearing.

    Noise-induced hearing loss: Repeated or sustained loud noise exposure causes permanent hair cell damage. Tinnitus in this context may be long-term, but sound therapy and other approaches can reduce its impact on daily life.

    Medication side effects: A range of medicines can cause or worsen tinnitus — including high-dose aspirin, some NSAIDs, certain antibiotics (particularly aminoglycosides), and some diuretics and chemotherapy drugs. If you suspect a medication is responsible, speak to your prescribing doctor before stopping anything.

    Menière’s disease: This inner ear condition causes episodes of vertigo, fluctuating hearing loss, and tinnitus. It is less common than noise-induced tinnitus but well-recognised, and there are treatments to reduce episode frequency.

    TMJ dysfunction: The jaw joint sits close to the ear canal. Problems with the temporomandibular joint can refer symptoms to the ear, including ringing. Dental or physiotherapy treatment aimed at the jaw can improve tinnitus in these cases.

    Group 3: Needs prompt attention

    These presentations should not wait for a routine appointment.

    Pulsatile tinnitus: If the sound you hear pulses in time with your heartbeat, this is different from the typical constant ringing. It can indicate abnormal blood flow near the ear — including vascular abnormalities that need imaging to evaluate. Serhal et al. (2022) classify sudden-onset pulsatile tinnitus as requiring immediate emergency assessment.

    Sudden onset in one ear, with hearing loss: Sudden sensorineural hearing loss is an otological emergency. The window for corticosteroid treatment is short — ideally within 72 hours of onset (Serhal et al., 2022). If you wake up with one ear significantly worse than the other, seek same-day medical attention.

    Tinnitus after a head injury: Research confirms that traumatic brain injury can cause tinnitus independently of any peripheral hearing damage (Le et al., 2024). New tinnitus following a head injury requires medical evaluation.

    What’s Actually Happening in Your Ear (and Brain)

    Understanding why tinnitus happens helps make sense of an experience that can otherwise feel mysterious and frightening.

    Your inner ear contains thousands of hair cells arranged along a structure called the cochlea. Each cluster of hair cells is tuned to a specific frequency. When those cells are damaged — by loud noise, ageing, or other causes — they send fewer or distorted signals up the auditory nerve to your brain.

    The brain’s auditory cortex, which expects a steady stream of input, responds to this reduction by turning up its own sensitivity. Think of it like a stereo amplifier that automatically increases its gain when the input signal drops. The result is that neurons in your central auditory system become more spontaneously active, generating signals that weren’t produced by any external sound. That internally generated activity is what you perceive as ringing.

    This mechanism — described in detail by Roberts (2018) — is known as central gain increase, or homeostatic plasticity. It explains something that surprises many people: tinnitus is fundamentally a brain phenomenon, not purely an ear problem. This is why the ringing often continues even after the original trigger (a noise event, an infection) has long passed. The peripheral damage has been done; the brain’s compensatory response persists.

    It also explains why tinnitus frequently accompanies hearing loss. According to the ATA, around 90% of people with tinnitus have some degree of hearing change, even if they haven’t been formally diagnosed with it.

    Temporary Ringing vs. Persistent Tinnitus: How to Tell the Difference

    Brief episodes of ear ringing — lasting a few seconds or minutes — are common and almost always benign. Most people experience them occasionally with no underlying significance.

    The situation is different when tinnitus follows a specific trigger, like a loud noise event. According to the American Tinnitus Association, when noise-induced tinnitus hasn’t resolved within 48 hours, the auditory system may have sustained more significant injury, and a GP or ENT assessment is worthwhile (American Tinnitus Association). This 48-hour figure is a practical guide based on clinical experience rather than the result of a controlled trial, but it maps closely to how primary care guidelines approach the question of when to act.

    Persistent tinnitus is defined clinically as lasting three months or more. At that point, the focus shifts from identifying a reversible cause to understanding the tinnitus and managing its impact. The earlier that process begins, the better — early assessment gives the best chance of identifying any treatable contributing factor before it becomes entrenched.

    If your tinnitus started more than a week ago and shows no sign of fading, a visit to your GP is a reasonable next step even if none of the red flag signs below apply to you.

    Red Flags: When to Seek Help Urgently

    Most tinnitus is not dangerous, and this section should not cause alarm. The following patterns are worth knowing precisely because they are different from typical tinnitus — and because early assessment genuinely changes outcomes.

    Pulsatile tinnitus (ringing or whooshing that beats in sync with your heartbeat): This can indicate abnormal blood flow near the ear, including arteriovenous malformations or other vascular findings. Sudden-onset pulsatile tinnitus warrants emergency evaluation (Serhal et al., 2022). The American Academy of Otolaryngology recommends imaging for pulsatile tinnitus as standard practice (American Academy of Otolaryngology-Head and Neck Surgery).

    Sudden hearing loss in one ear: If you notice significant hearing loss in one ear — particularly if it came on overnight or over a few hours — this is a medical emergency. Sudden sensorineural hearing loss (SSNHL) is treatable with corticosteroids, but the treatment window is short. Serhal et al. (2022) recommend ENT referral within 24 hours for tinnitus with sudden-onset hearing loss occurring within the last 30 days.

    Tinnitus with neurological symptoms: If tinnitus is accompanied by facial weakness, sudden vertigo, difficulty swallowing, or any sign of stroke, seek emergency care immediately (National Institute for Health and Care Excellence, 2020).

    Tinnitus following head injury: New tinnitus after any head trauma warrants evaluation, even if the injury seemed minor (Le et al., 2024).

    For all other presentations — constant ringing in both ears, tinnitus that has built up gradually, tinnitus that fluctuates with stress or tiredness — a standard GP appointment is appropriate rather than urgent.

    If your tinnitus pulses with your heartbeat, came on suddenly in one ear with hearing loss, or followed a head injury, contact a doctor the same day or go to an emergency department.

    Key Takeaways

    Ringing ears is one of the most common auditory complaints there is — affecting around 1 in 7 adults (Jarach et al., 2022). In the large majority of cases, it traces back to inner ear disruption from noise exposure or age-related changes, and it is not a sign of anything dangerous.

    Knowing which category your experience falls into — temporary, ongoing but manageable, or one of the specific red-flag patterns — is the most useful first step you can take. If the ringing has lasted more than 48 hours, a GP visit is worthwhile: early assessment identifies any treatable cause and opens the most options. For the vast majority of people, tinnitus is not a signal of serious disease — but you don’t have to leave it unexamined.

  • Meniere’s Disease and Tinnitus: Symptoms, Diagnosis, and How They Differ

    Meniere’s Disease and Tinnitus: Symptoms, Diagnosis, and How They Differ

    Tinnitus and Meniere’s Disease: Should You Be Worried?

    If you have tinnitus — especially in one ear — and you’ve come across Meniere’s disease while searching for answers, it is completely understandable to feel frightened. The word alone sounds serious, and reading about its symptoms can make your own experience feel suddenly ominous.

    Here is what this article will help you understand: what Meniere’s disease actually is, how its tinnitus differs from the more common kinds, what a diagnosis involves, and, most practically, whether your symptoms are the sort that warrant a call to your doctor. Most people with tinnitus do not have Meniere’s disease. But understanding the difference matters, and by the end of this article, you will have a clear picture of where your symptoms fit.

    What Is Meniere’s Disease, and What Does It Have to Do With Tinnitus?

    Meniere’s disease causes tinnitus as one of four cardinal symptoms (alongside vertigo, fluctuating low-frequency hearing loss, and aural fullness), but the tinnitus is characteristically low-pitched and roaring, and almost always accompanied by dizziness and hearing changes. This distinguishes it from the more common high-pitched tinnitus caused by noise exposure or ageing. Tinnitus alone does not indicate Meniere’s disease.

    Meniere’s disease is a chronic inner ear disorder in which fluid pressure builds up in the endolymphatic compartment of the cochlea and vestibular system. This pressure disrupts both hearing and balance, producing the four symptoms above in episodic attacks.

    The condition is relatively rare: estimates suggest it affects around 0.1–0.2% of the population, with onset most common between the ages of 40 and 60. It usually begins in one ear, though clinical estimates suggest 15–30% of patients develop some bilateral involvement over time. Across 18 randomised controlled trials reviewed by Ahmadzai et al. (2020), tinnitus was consistently identified as a core defining feature — but always alongside the other three symptoms, never in isolation.

    One clinical distinction worth knowing: clinicians use the term Meniere’s disease specifically for the idiopathic form, where no underlying cause is found. When the same symptoms arise from a known secondary cause such as autoimmune dysfunction, hypothyroidism, or trauma, the term Meniere’s syndrome is used instead, and management focuses on treating that underlying cause (Medscape Reference, 2023).

    What Does Meniere’s Tinnitus Actually Sound Like?

    Most people associate tinnitus with a high-pitched ringing or hissing — the kind that can follow a loud concert or develop gradually with age-related hearing loss. Meniere’s tinnitus is different in character.

    In Meniere’s disease, the tinnitus tends to be low-pitched: a roaring, rumbling, or droning sound, sometimes described as the low hum of an engine or the sound of wind. Research by Ueberfuhr et al. (2016) found that Meniere’s tinnitus is typically dominated by frequencies below 1 kHz, with many patients perceiving sounds concentrated around 125–250 Hz. By contrast, tinnitus in non-hydropic conditions such as noise-induced or age-related hearing loss tends to be higher in frequency.

    This difference has a mechanical basis. In Meniere’s disease, excess endolymphatic pressure distorts the basilar membrane at the low-frequency end of the cochlea, producing a low-frequency phantom sound. Noise-induced or age-related tinnitus, in contrast, reflects damage to the hair cells that process higher frequencies, which is why it typically sounds like a high-pitched tone or hiss.

    The pattern over time is also different. In early Meniere’s disease, tinnitus tends to fluctuate: it worsens in the hours or days before an attack, intensifies during it, then partially subsides afterwards. Kutlubaev et al. (2020) describe this as a characteristic warning pattern for the condition. As the disease progresses and permanent cochlear damage accumulates, the tinnitus becomes more constant and may shift toward higher pitches in some patients as hair cell damage extends beyond the low-frequency regions (Ueberfuhr et al., 2016).

    FeatureMeniere’s tinnitusTypical noise/age-related tinnitus
    PitchLow — roaring, rumbling, droningHigh — ringing, hissing, whistling
    PatternFluctuates with attacks; worsens before/during episodesUsually constant from onset
    Associated symptomsVertigo, hearing fluctuation, ear pressureOften none, or mild sound sensitivity
    Onset sideTypically unilateral, at least early onCan be bilateral

    The Full Symptom Picture: Why Tinnitus Alone Isn’t Enough

    Meniere’s disease is not a tinnitus diagnosis. Clinicians require the full cluster of four symptoms before the condition is seriously considered, and diagnostic criteria set a high bar.

    The Bárány Society (2015) consensus criteria — the international standard for diagnosing Meniere’s disease — specify that a definite diagnosis requires at least two spontaneous rotational vertigo episodes each lasting between 20 minutes and 12 hours, audiometrically documented low-to-mid frequency sensorineural hearing loss, and fluctuating ear symptoms (tinnitus or aural fullness) in the affected ear. A probable diagnosis requires at least one vertigo episode plus documented hearing loss and either tinnitus or aural fullness.

    To understand what this means in practice, it helps to look at each of the other three symptoms:

    Episodic rotational vertigo. This is not light-headedness or a general sense of unsteadiness. Meniere’s vertigo is a true sensation of spinning — the room rotating around you — lasting at least 20 minutes and sometimes several hours. These episodes can be severely disabling, with nausea, vomiting, and an inability to stand. They arrive unpredictably, which is a major source of anxiety for people with the condition.

    Fluctuating hearing loss. The hearing loss in Meniere’s affects low-to-mid frequencies first (in contrast to the high-frequency loss typical of ageing or noise exposure). In the early stages, hearing may partially recover between attacks. Over time, as Kutlubaev et al. (2020) note, the loss becomes increasingly permanent.

    Aural fullness. Many patients describe this as a sense of pressure, heaviness, or a “blocked” or “underwater” feeling in the affected ear. This symptom often appears as a warning sign before an attack begins.

    One clinically recognised pattern worth knowing: in some patients, tinnitus and aural fullness can precede the first vertigo episode by months or even longer. If you have had persistent one-sided tinnitus and ear pressure but no vertigo yet, this does not mean Meniere’s is unlikely — it may simply mean the condition is still in its early stages. This pattern is described in clinical reviews including Kutlubaav et al. (2020), though specific percentage figures from cohort studies were not available in the evidence reviewed for this article.

    In early Meniere’s, attacks may be separated by long symptom-free periods. This intermittent quality is part of why the condition can take time to diagnose.

    How Is Meniere’s Disease Diagnosed?

    There is no single test that definitively confirms Meniere’s disease. It is diagnosed through a combination of clinical history, audiometric testing, and the systematic exclusion of other conditions.

    The Bárány Society (2015) two-tier criteria provide the framework clinicians use. As described above, a definite diagnosis requires documented vertigo episodes of the right duration, confirmed low-frequency sensorineural hearing fluctuation on audiometry, and the associated ear symptoms — in the absence of any other explanation. A probable diagnosis can be made with fewer confirmed episodes.

    Audiometry is a key part of this process. Because Meniere’s hearing loss is characteristically low-frequency and fluctuating, serial audiograms (taken at different time points) can document the pattern in a way that a single test cannot.

    MRI of the inner ear and brain is used not to confirm Meniere’s but to exclude alternatives — particularly vestibular schwannoma (acoustic neuroma), a benign tumour of the vestibulocochlear nerve that can produce one-sided tinnitus, hearing loss, and dizziness. This is especially important because acoustic neuroma can mimic Meniere’s closely in its early stages.

    The differential diagnosis list is longer than many patients realise. Vestibular migraine is the most frequently confused condition: a study by Zhang et al. (2025) comparing 108 vestibular migraine patients with 65 Meniere’s disease patients found significant clinical overlap and frequent misdiagnosis between the two conditions. Caloric vestibular testing — which measures how each ear responds to temperature-induced fluid movement — was the most reliable distinguishing test, with significant canal paresis on that test pointing toward Meniere’s rather than vestibular migraine. Other conditions that must be excluded include vestibular neuronitis, labyrinthitis, and in rare cases brainstem stroke.

    One detail that can be reassuring: bilateral symptoms (tinnitus and hearing loss affecting both ears from the start, combined with vertigo) make Meniere’s disease less likely and vestibular migraine more likely. Meniere’s, at least in early stages, is almost always unilateral.

    Diagnosis can take time — sometimes years — because the episodic nature of the condition means the full symptom picture may not be evident at first presentation. This is precisely why ENT referral matters rather than attempting to self-diagnose.

    When Should Tinnitus Make You Think of Meniere’s? A Practical Guide

    This is the question most people searching this topic actually want answered: should I be worried?

    The honest answer is that Meniere’s disease is unlikely to be the cause of your tinnitus if your tinnitus is bilateral, high-pitched, and has been constant from the beginning with no associated hearing changes or balance symptoms. This describes the majority of people with tinnitus.

    Meniere’s disease is more likely to come into the differential picture when tinnitus has this profile:

    • Unilateral — affecting one ear only
    • Low-pitched in quality — roaring, rumbling, droning rather than ringing or hissing
    • Fluctuating — noticeably worse before or during episodes of dizziness, then easing
    • Accompanied by hearing changes — particularly for low tones, and particularly changes that vary over time
    • Accompanied by ear pressure or fullness
    • Accompanied by episodes of true rotational vertigo lasting at least 20 minutes

    None of these features alone confirms Meniere’s. But the combination of several of them — especially unilateral tinnitus plus episodic vertigo plus hearing fluctuation — is the pattern that warrants ENT evaluation.

    A separate and important red flag applies regardless of whether Meniere’s is suspected: RCGP/NICE (2022) guidance identifies unilateral tinnitus combined with persistent or fluctuating hearing loss as an explicit indication for ENT referral, partly to exclude acoustic neuroma. You do not need to have vertigo for this referral to be appropriate. One-sided tinnitus with any associated hearing change should always be assessed by a doctor or audiologist.

    If you have one-sided tinnitus with hearing loss or dizziness, see your GP. The goal is not to diagnose yourself with Meniere’s disease — it is to rule out conditions, including acoustic neuroma, that need professional evaluation. RCGP/NICE (2022) guidelines list this combination as a red flag for ENT referral.

    Tinnitus alone — even if it is one-sided — does not mean you have Meniere’s disease. Meniere’s requires a specific cluster of symptoms including true rotational vertigo and documented hearing fluctuation. However, unilateral tinnitus with any hearing or balance symptoms always warrants a professional assessment.

    The Key Takeaway: Tinnitus Is a Symptom, Not a Diagnosis

    Finding Meniere’s disease while searching about tinnitus can feel alarming — and if that’s what brought you here, your concern is completely understandable. Tinnitus is distressing enough on its own, without the added anxiety of wondering whether something more serious is behind it.

    Here is what the evidence actually tells us.

    Meniere’s disease causes tinnitus, but tinnitus does not mean Meniere’s disease. The condition affects around 0.1–0.2% of the population, and it produces a distinctive cluster of symptoms: low-pitched, fluctuating tinnitus; episodic rotational vertigo lasting at least 20 minutes; low-frequency hearing loss that changes over time; and a sense of pressure or fullness in the affected ear. Tinnitus sitting alongside all of these is a different clinical picture from tinnitus alone.

    The tinnitus of Meniere’s has a recognisable character — a roaring or rumbling low sound, worsening before attacks — that is different from the steady high-pitched ringing most people with tinnitus experience (Ueberfuhr et al., 2016). If your tinnitus is high-pitched, bilateral, and constant, Meniere’s disease is an unlikely explanation.

    If you have one-sided tinnitus with any hearing changes or balance symptoms, see your GP or an ENT specialist. Not because it is definitely Meniere’s, but because those symptoms together always deserve a professional look — both to identify any treatable cause and to rule out the small number of conditions, such as acoustic neuroma, that require attention. RCGP/NICE (2022) guidelines are clear on this point.

    And if you do receive a Meniere’s diagnosis at some point: the condition is chronic, and it can be serious during attacks, but it is manageable. Many people find that attack frequency decreases over time, and there are established options — from dietary changes to medical treatments — that can reduce the burden significantly (Kutlubaev et al., 2020). A diagnosis is the beginning of a path to management, not a sentence.

    Most tinnitus does not have a dangerous underlying cause. Understanding the difference between Meniere’s tinnitus and the more common kinds is the first step toward knowing whether your symptoms need further investigation — and in many cases, toward a quieter mind, if not a quieter ear.

  • Acoustic Neuroma and Tinnitus: Symptoms, Diagnosis, and What to Expect

    Acoustic Neuroma and Tinnitus: Symptoms, Diagnosis, and What to Expect

    One-Sided Ringing and a Diagnosis You Weren’t Expecting

    Hearing that a tumour might be the cause of ringing in your ear is frightening, even when a doctor reassures you it is benign. If you are in that position right now, you are dealing with something genuinely alarming, and that reaction makes complete sense. The good news is substantial: acoustic neuroma is non-cancerous, does not spread to other parts of the body, grows slowly (often over many years), and affects roughly 1 in 100,000 people per year. The medical term is vestibular schwannoma — acoustic neuroma is the older, more commonly used name, and both refer to the same thing.

    This article explains what acoustic neuroma is, why it causes one-sided tinnitus, how the diagnosis is reached, and — most importantly — what you can realistically expect regarding your tinnitus across the three main management paths.

    What Is Acoustic Neuroma and Why Does It Cause Tinnitus?

    Acoustic neuroma grows from Schwann cells on the vestibulocochlear nerve (cranial nerve VIII), the nerve responsible for both hearing and balance. As the tumour expands within the internal auditory canal, it compresses the cochlear branch of that nerve, disrupting the normal flow of auditory signals to the brain. The brain perceives this disruption as sound, which is the tinnitus you hear.

    Because the tumour sits on one side, this tinnitus is ipsilateral: it occurs in the same ear as the tumour. That one-sided, persistent quality is precisely what makes it clinically significant. Common tinnitus is usually bilateral or affects both ears at different times. When tinnitus is persistent and confined to a single ear, particularly when it is accompanied by hearing change on the same side, it is the defining red flag that warrants further investigation. Approximately 70% of people with acoustic neuroma have tinnitus at the point of diagnosis.

    Symptoms: What Acoustic Neuroma Feels Like

    Acoustic neuroma produces a recognisable pattern of symptoms, though their severity varies considerably depending on tumour size and how quickly it has grown.

    Progressive unilateral hearing loss is the most common symptom and is usually the first to appear. It tends to be gradual, affecting high frequencies first, and may be so slow that you attribute it to ageing or background noise. In around one in ten cases, hearing loss arrives suddenly rather than gradually, and sudden hearing loss in one ear is a medical urgency (more on this below).

    Tinnitus is present in roughly 70% of patients at diagnosis. It typically sounds like a persistent ringing, buzzing, or hissing, and occurs in the affected ear only. It may be constant or come and go. This ipsilateral quality — same ear as the hearing loss — is what separates acoustic neuroma tinnitus from the far more common bilateral tinnitus that affects millions of people without any structural cause.

    Vestibular symptoms — including dizziness, unsteadiness, or a sense of imbalance — are common because the tumour also affects the balance branch of cranial nerve VIII. Acute spinning vertigo (the room-spinning sensation of classic vertigo) is less typical; more often, people describe a general unsteadiness or feeling of being slightly off-balance.

    As the tumour grows larger, it may compress neighbouring structures, producing additional symptoms:

    • Facial numbness or tingling, from pressure on the trigeminal nerve (cranial nerve V)
    • Facial weakness, from involvement of the facial nerve (cranial nerve VII), which runs in close proximity
    • Headache or a feeling of pressure, which can develop if the tumour grows large enough to raise intracranial pressure

    Smaller tumours, which are increasingly found because of greater awareness and improved imaging, often produce only hearing loss and tinnitus, without any of these later-stage features.

    How Is Acoustic Neuroma Diagnosed?

    The diagnostic process follows a well-established sequence, and most small tumours are identified before they cause serious problems.

    Step 1: GP or ENT assessment. The process typically begins when you report persistent one-sided tinnitus, asymmetric hearing loss, or unexplained dizziness to your GP. Based on your symptom history, they will refer you for a hearing test or directly to an ENT specialist.

    Step 2: Audiogram. A formal hearing test (audiogram) is usually the first investigation. Acoustic neuroma typically produces asymmetric sensorineural hearing loss, meaning the nerve-based hearing loss is noticeably worse in one ear than the other. In the UK, NICE guidelines recommend MRI referral when there is an asymmetry of 15 dB or more at two adjacent frequencies (NICE NG98). An audiogram that shows this pattern is the key trigger for imaging.

    Step 3: MRI with gadolinium contrast. MRI is the gold standard for diagnosing acoustic neuroma. The gadolinium contrast agent makes even small tumours visible on the scan. CT scanning is not reliable for detecting small acoustic neuromas and may miss them entirely, which is why MRI is always preferred when this diagnosis is being considered.

    Two additional tests may be ordered to gather more information about nerve function:

    • Auditory brainstem response (ABR) testing assesses how efficiently the auditory nerve transmits signals to the brain
    • Electronystagmography (ENG) evaluates vestibular function and may reveal reduced response on the affected side

    Neither of these confirms the diagnosis on its own, but both can guide the clinical picture before or alongside MRI.

    The Three Management Options — and What They Mean for Your Tinnitus

    This is where acoustic neuroma management differs from what many patients expect, and where honest information matters most.

    There are three established approaches: watchful waiting (observation), microsurgery, and stereotactic radiosurgery. The 2024 Clinical Practice Guideline on vestibular schwannoma management confirms that none of these approaches consistently eliminates tinnitus, and that treatment decisions should be made through shared decision-making based on tumour size, growth rate, symptoms, and patient preference (Lassaletta et al., 2024). There is almost never a clinical reason to rush a decision.

    Watchful waiting (observation)

    For small or stable tumours, active monitoring with serial MRI scans every 6 to 12 months is a legitimate and commonly chosen path. The aim is to detect any significant growth before it becomes a problem, rather than to treat a tumour that may never progress meaningfully.

    From a tinnitus perspective, watchful waiting neither reliably worsens nor improves it. A systematic review comparing watchful waiting against stereotactic radiosurgery in 1,635 patients found no significant difference in tinnitus outcomes between the two groups (Vasconcellos et al., 2024). This is both reassuring and realistic: observation is not a passive acceptance of worsening symptoms, but it is not a tinnitus treatment either.

    Microsurgery

    Surgical removal aims to take out the tumour entirely. For many patients, particularly those with larger or growing tumours, it remains the most appropriate option.

    Regarding tinnitus, the evidence is clear and patients deserve to know it: surgery does not reliably eliminate tinnitus. A systematic review and meta-analysis of 13 studies involving 5,814 patients found no significant difference in tinnitus outcomes between microsurgery and stereotactic radiosurgery, and the authors concluded that “no definitive conclusions could be drawn favouring either treatment” (Ramkumar et al., 2025). A separate observational study of 450 surgical patients found that surgery can worsen pre-existing tinnitus, and can even trigger new-onset tinnitus in patients who had none beforehand (Geng et al., 2025). Patients with serviceable hearing before surgery faced higher odds of both worsened and new-onset tinnitus post-operatively.

    Hearing preservation is more likely when the tumour is smaller and detected early, which is another reason prompt investigation of one-sided symptoms matters.

    Stereotactic radiosurgery (e.g., Gamma Knife)

    Radiosurgery uses precisely targeted radiation to stop the tumour from growing; it does not remove the tumour. Most patients treated this way retain a stable but present tumour for the rest of their lives, without it causing further harm.

    Tinnitus outcomes after radiosurgery are similarly variable and unpredictable. A network meta-analysis across multiple treatment modalities suggested radiosurgery may offer a slight advantage over microsurgery for tinnitus improvement, though the certainty of evidence was rated low given that most included studies were observational rather than randomised (Huo et al., 2024). Radiosurgery’s main advantage is avoiding the operative risks of open surgery while still controlling tumour growth.

    The honest picture

    Across all three paths, the consistent finding is that tinnitus outcomes are unpredictable. Some people see improvement; others experience no change; a proportion find tinnitus worsens, particularly after surgery. What treatment does reliably accomplish is controlling the tumour, and for a benign growth that is not going to spread, that is the primary goal. Tinnitus management after diagnosis typically involves the same approaches used for tinnitus of other causes: counselling, sound therapy, and hearing rehabilitation where relevant.

    When to See a Doctor: Red Flags You Shouldn’t Ignore

    If you have tinnitus and are wondering whether it warrants medical attention, the following guidance is intended to help you decide clearly, without alarm, but without delay where delay matters.

    Persistent tinnitus in one ear only, particularly if it has lasted more than a few weeks and is accompanied by any hearing change on the same side, should prompt a visit to your GP to arrange an audiogram. Most one-sided tinnitus has far more common causes than acoustic neuroma, such as earwax, middle ear fluid, or noise exposure, but acoustic neuroma is the most important condition to exclude, which is why the investigation pathway exists.

    Sudden hearing loss in one ear is a medical urgency. If you wake up with significantly reduced hearing in one ear, or if hearing drops sharply over a few hours, seek same-day medical attention. Corticosteroid treatment for sudden sensorineural hearing loss should begin as soon as possible, ideally within the first two weeks; benefit has been reported up to six weeks from onset, but outcomes are better with earlier treatment (AAO-HNS 2019 CPG). Do not wait for a routine appointment.

    Tinnitus combined with dizziness, balance problems, or facial weakness or numbness warrants prompt ENT referral, as this combination suggests involvement of structures beyond the cochlear nerve alone.

    Acoustic neuroma affects roughly 1 in 100,000 people per year. The vast majority of one-sided tinnitus is not caused by a tumour. But the investigation, an audiogram followed by MRI if asymmetry is confirmed, is straightforward, and identifying a small acoustic neuroma early gives you and your clinical team the widest range of options.

    Key Takeaways

    Acoustic neuroma is a rare but important cause of one-sided tinnitus. It is benign, does not spread, and in most cases grows slowly enough that you and your doctors have real time to consider options carefully.

    The key red flag is persistent tinnitus in one ear, especially when combined with hearing loss on the same side. That combination warrants an audiogram and, if asymmetry is confirmed, an MRI.

    If you receive a diagnosis, the most important thing to understand upfront is that none of the three management options, whether observation, surgery, or radiosurgery, reliably eliminates tinnitus. Knowing this from the start allows you to set realistic expectations and focus treatment decisions on what they do achieve: controlling the tumour. Diagnosis is not a crisis. Most people with acoustic neuroma lead full, active lives.

  • Noise-Induced Tinnitus: Causes, Timeline, and What You Can Do

    Noise-Induced Tinnitus: Causes, Timeline, and What You Can Do

    When the Ringing Won’t Stop After Loud Noise

    The buzzing in your ears after a concert, a gunshot, or a loud power tool is one of the most unsettling sounds a person can experience, especially when it refuses to fade. Your first question is almost certainly the same one most people ask: will this go away? The honest answer is that it depends on what happened inside your ear during that noise exposure, and the biology behind that distinction is actually something you can act on. This article explains what noise-induced tinnitus is, what drives the outcome, and what you can do right now.

    The Short Answer: Why Noise-Induced Tinnitus Happens

    Noise-induced tinnitus occurs when loud sound overloads the sensory hair cells inside your cochlea. Unable to receive normal input from those cells, the auditory brain compensates by increasing its own internal sensitivity — a process called central gain upregulation — and this heightened activity is what you perceive as ringing, buzzing, or hissing.

    Two outcomes are possible. In a temporary threshold shift (TTS), the hair cells are metabolically fatigued but structurally intact. Tinnitus and muffled hearing may resolve within hours to days as the cells recover. In a permanent threshold shift (PTS), the hair cells are physically destroyed and cannot regenerate. When that happens, the auditory brain’s compensatory activity is more likely to persist — and so is the tinnitus (Ryan et al. (2016)).

    The critical question in those first hours after a loud exposure is which of these two things has happened.

    What Happens Inside Your Ear During Loud Noise Exposure

    Your cochlea contains thousands of tiny sensory hair cells arranged along a spiral structure. Each group responds to a specific frequency: the cells at the base handle high-pitched sounds, those deeper in the spiral handle low frequencies. These cells do one job — convert the mechanical motion of sound waves into electrical signals the brain can read.

    When sound is too loud or lasts too long, those cells are overwhelmed. Audiological consensus identifies approximately 85 dB as the threshold above which prolonged exposure begins to cause cumulative damage — roughly the level of a lawnmower or heavy traffic. At levels around 115–120 dB, which concerts routinely reach, damage can begin almost immediately.

    Above those thresholds, several things happen at the cellular level. Intense vibration generates reactive oxygen species — essentially free radicals — that trigger stress pathways inside the hair cells, and in severe cases, cell death (Ryan et al. (2016)). The high-frequency region of the cochlea, roughly 4–6 kHz, is the most vulnerable, which is why noise-induced hearing damage typically shows up first as a characteristic notch in hearing tests at those frequencies.

    When the brain receives less input from damaged hair cells, it does what any signal-processing system does when the incoming signal weakens: it turns up the gain. Think of an amplifier cranked higher to compensate for a fading radio signal. The result is that auditory neurons fire more spontaneously and vigorously than before, and that excess neural activity is what you hear as tinnitus (NHANES 1999–2020 study (vault note) (2025)).

    One additional mechanism worth knowing about: even when hearing thresholds appear to recover fully, large numbers of cochlear synapses — the connections between hair cells and auditory nerve fibres — can be silently lost. This cochlear synaptopathy may explain why some people have persistent tinnitus even after a hearing test comes back normal (Ryan et al. (2016)).

    The Timeline: What the First Hours, Days, and Weeks Tell You

    There is no precise formula that predicts whether your specific tinnitus will resolve, but the timeline does carry meaningful information.

    First 16–48 hours: Most tinnitus that follows a single noise exposure falls into TTS territory. The hair cells have been stressed, not necessarily destroyed. During this window, the priority is acoustic rest — keeping your auditory system as quiet as possible so those cells can recover. Avoid loud environments, do not use headphones, and try not to fixate on the sound by testing it in complete silence, which tends to increase anxiety.

    One to two weeks: If the tinnitus is clearly reducing day by day, recovery is likely continuing. If it has stabilised or seems worse, this is the window to see an ear, nose, and throat (ENT) specialist. Some clinicians recommend corticosteroids for acute acoustic trauma, ideally within 24–72 hours of the exposure, to reduce cochlear inflammation and support recovery — though it should be noted this recommendation is based on expert consensus and analogy from sudden hearing loss guidelines, not from clinical trials specific to acoustic trauma (StatPearls / NCBI Bookshelf (2024)). Waiting to see whether it resolves on its own is understandable, but it carries the risk of missing that window.

    One month: Tinnitus that has persisted for a month without meaningful improvement is more likely to become chronic. It is worth being precise about what chronic means here: persistent, but not necessarily unchanging. Chronic tinnitus can still reduce in perceived intensity over time, become less intrusive as your nervous system habituates to it, and be managed with sound therapy and other approaches.

    Three to twelve months: At this stage, management rather than resolution becomes the realistic goal. The evidence base for tinnitus management — cognitive behavioural therapy, sound enrichment, hearing aids where there is co-existing hearing loss — is solid, and many people with chronic tinnitus report significant improvement in quality of life even when the sound itself does not disappear.

    One practical distinction worth knowing: the VA/DoD clinical guidelines differentiate between transient ear noise lasting less than five minutes, which is common and typically needs no intervention, and tinnitus that persists beyond that window. Persistent post-exposure tinnitus is the signal to take the steps in the next section.

    What You Can Do: Immediate Steps and Longer-Term Options

    Right now (first 24–72 hours)

    Give your ears complete acoustic rest. No headphones, no loud environments, no concerts or bars. This is not precautionary caution — it has direct biological rationale. The hair cells that were stressed during the exposure need time and a quieter environment to recover. Re-exposure to loud sound during this window significantly raises the risk of converting a TTS into a PTS.

    Avoid known ototoxic substances. High doses of aspirin and alcohol have been associated with temporary worsening of tinnitus, though solid data on their effect during the acute recovery window specifically is limited. Avoiding both in the short term is reasonable.

    Do not repeatedly test your hearing in silence. Many people sit in quiet rooms and listen intently for the tinnitus. This increases hypervigilance and anxiety, which can amplify how loud the sound seems. Gentle background sound — a fan, soft music at a comfortable volume — is often better than silence.

    Hydration and warm compresses are sometimes suggested online. There is no direct clinical evidence they accelerate tinnitus recovery after acoustic trauma, so they should not substitute for the steps above.

    If tinnitus persists beyond one to two weeks

    See an ENT or audiologist. Get a formal audiogram to quantify any hearing loss — this tells you and your doctor whether a PTS has occurred and at which frequencies. It also establishes a baseline for monitoring.

    Ask about the treatment window. If you are within roughly 4 weeks of the exposure, your ENT may consider corticosteroids. As noted, this is based on clinical consensus rather than trial evidence specific to acoustic trauma, and your doctor can weigh whether it is appropriate for your situation (StatPearls / NCBI Bookshelf (2024)).

    Explore sound enrichment. One of the most practical early strategies is reducing the perceptual contrast between the tinnitus and ambient sound. Low-level background sound — nature sounds, white noise, or a hearing aid if hearing loss is present — makes the tinnitus less prominent without any medical intervention required.

    Hearing protection going forward. According to the American Tinnitus Association, standard earplugs attenuate sound by up to 33 dB, earmuffs by up to 31 dB, and using both together provides around 36 dB of combined protection (American). Custom musician’s earplugs offer flat-curve attenuation, reducing volume without distorting pitch or clarity — useful if you play music or attend live events regularly.

    Who Is Most at Risk?

    Noise-induced tinnitus is not evenly distributed. Occupational exposure is a major driver: factory workers, construction workers, military personnel, and professional musicians all face sustained exposure above the 85 dB damage threshold. People with consistent exposure to loud noise at work are more than three times as likely to have tinnitus compared to those without such exposure, and those with recreational noise exposure are about 2.6 times more likely (Bhatt et al. (2016)).

    Recreational exposure is an underappreciated risk. Concerts, nightclubs, shooting ranges, and even personal audio devices at high volume contribute to the burden, and tinnitus due to recreational noise is now described as a major public health concern (Loughran et al. (2020)).

    Adolescents are a risk group that often goes unnoticed. Hearing protection use tends to be low among young people, and noise risk behaviour — high-volume headphone use and frequent concert attendance — peaks during teenage and early adult years, often before any hearing consequences are apparent.

    Individual susceptibility also matters. Pre-existing hearing loss, advancing age, and genetic factors can make some people’s auditory systems more vulnerable to a given noise dose. According to the American Tinnitus Association, approximately 90% of people with tinnitus have some degree of noise-induced hearing loss (American).

    Cumulative exposure and acute exposure carry different profiles. A single extremely loud event — a gunshot or explosion at close range — can produce immediate PTS. Repeated moderate exposures over years, each appearing to resolve, progressively deplete the cochlear hair cell population and the reserve of cochlear synapses, until a threshold is crossed and tinnitus becomes chronic.

    Key Takeaways

    • Noise-induced tinnitus is the most common form of tinnitus. It is caused by cochlear hair cells being stressed or destroyed by loud sound, with the brain generating phantom sound to compensate for lost input.
    • TTS vs. PTS is the central question. If hair cells are only metabolically fatigued (TTS), recovery is possible. If they are physically destroyed (PTS), the change is permanent. Cochlear synaptopathy can cause persistent tinnitus even when a standard hearing test appears normal.
    • Give your ears acoustic rest immediately after a loud noise exposure and avoid any further loud sound in the following days.
    • If ringing continues beyond one to two weeks without clear improvement, see an ENT. A treatment window may exist, and a formal hearing test will tell you whether hearing loss has occurred.
    • Hearing protection is the single most effective preventive action. Earplugs, earmuffs, or custom musician’s earplugs all reduce the noise dose reaching your cochlea before any damage can occur.

    Noise-induced tinnitus is a signal your auditory system sends when it has been pushed too hard — taking that signal seriously, especially early, is the most useful thing you can do.

  • COVID and Tinnitus: What the Research Says About Onset and Recovery

    COVID and Tinnitus: What the Research Says About Onset and Recovery

    Why Is My Ear Ringing After COVID?

    If you’ve recovered from COVID-19 and now have a ringing, buzzing, or humming in your ears that wasn’t there before, it’s natural to feel alarmed. You might be wondering whether this is connected to your illness, whether it will go away, and whether you need to see a doctor. These are the right questions to ask, and there are real answers.

    This article covers how common tinnitus after COVID actually is, why the infection can affect your hearing, and what the evidence says about recovery. The short version: COVID tinnitus is a documented, recognised phenomenon. Whether it resolves depends in part on how severe it is at onset, and that distinction matters for what you do next.

    Can COVID-19 Cause Tinnitus?

    Yes. COVID-19 is associated with new-onset tinnitus and the worsening of pre-existing tinnitus. Depending on the study and the population examined, somewhere between roughly 5% and 28% of people who have had COVID-19 report tinnitus afterwards.

    The range is wide because it reflects genuine differences in study design. A 2022 meta-analysis of 12 studies found a pooled tinnitus rate of around 4.5% across largely hospital-based acute-phase cohorts (Jafari et al., 2022). A larger cross-sectional survey of 1,331 post-COVID respondents found a prevalence of 27.9% (Mao et al., 2024). A 2026 meta-analysis of cohort studies using physician-diagnosed outcomes found no statistically significant pooled association overall (Liu et al., 2026), which shows how much the answer depends on who is studied and how tinnitus is measured.

    COVID-19 can trigger new-onset tinnitus in a meaningful proportion of survivors. Estimates vary widely across studies — from around 5% to 28% — depending on whether researchers studied hospitalised patients, mild-case survivors, or long-COVID clinic populations. The figure is real, even if the exact number is uncertain.

    What is consistent across studies is that the association is real and that it affects people across the spectrum of COVID severity, not just those who were seriously ill. Worsening of pre-existing tinnitus is also well-documented.

    When Does COVID Tinnitus Start — and Why Does Timing Matter?

    Not everyone who develops tinnitus after COVID notices it at the same point in their illness. Research points to three distinct onset windows, and understanding which applies to you can help clarify what is likely driving it.

    During the acute illness phase. Some people notice tinnitus while they are still actively sick — during the first one to two weeks of infection. This most likely reflects direct cochlear involvement: inflammation, reduced blood flow, or early viral effects on the inner ear during the height of the immune response.

    During treatment. A subset of cases appear to begin during COVID treatment rather than from the infection itself. Corticosteroids, sometimes prescribed for COVID, are among the medications that can independently affect tinnitus perception. Separating drug effects from viral effects in this window is genuinely difficult, and the research doesn’t fully resolve it.

    After recovery — delayed onset. Some people develop tinnitus days or weeks after they have otherwise recovered. One audiometric study found that tinnitus onset averaged around 30 days after the initial COVID symptoms. This delayed pattern may reflect a different underlying process: post-inflammatory changes in the central auditory system, or ongoing immune activation rather than the direct cochlear effects more likely in the acute phase.

    The timing matters clinically because it shapes how you understand the likely cause. Tinnitus appearing during acute illness suggests peripheral (inner ear) involvement. Tinnitus appearing weeks after recovery, without any other hearing change, is more likely to involve central auditory pathways — a distinction that affects how the condition is managed.

    Why Does COVID Affect Your Hearing? The Biology in Plain Language

    Your cochlea — the spiral-shaped structure in your inner ear that converts sound into nerve signals — contains cells that carry a protein on their surface called ACE2. This is the same receptor that SARS-CoV-2 uses to enter cells throughout the body. Animal studies have confirmed that ACE2, along with related proteins that help the virus enter cells, is present in cochlear hair cells, the stria vascularis, and the spiral ganglion (Uranaka et al., 2021). This establishes the biological plausibility that the virus can, in principle, directly affect the inner ear.

    Here is the chain of events researchers believe may occur:

    1. Viral or inflammatory damage to cochlear hair cells. Hair cells are the sensory cells that detect sound vibrations. They do not regenerate once lost. If the virus or the immune response triggered by it damages these cells, the cochlea sends fewer signals to the brain.

    2. The brain compensates by turning up its internal volume. When the brain receives less input from the ear, it tends to amplify its own activity to compensate. This process — called central gain upregulation — can produce phantom sounds that feel just as real as external noise. That is tinnitus.

    3. Auditory pathway involvement beyond the cochlea. Objective audiometric testing of long-COVID patients found significantly prolonged signal transmission times through the brainstem auditory pathway, suggesting that nerve damage extends beyond the inner ear itself (Dorobisz et al., 2023).

    4. Mechanical causes from the upper airway. Eustachian tube dysfunction — common during and after any upper respiratory infection — can cause ear fullness and muffled hearing that temporarily triggers or worsens tinnitus through a simpler mechanical route, without any cochlear damage at all.

    No single mechanism has been confirmed as the primary cause of COVID-related tinnitus, and it likely varies between individuals. Anxiety and poor sleep — both common during and after COVID illness — can independently intensify tinnitus perception regardless of the underlying cause. Some COVID medications may also play a role.

    If your tinnitus started during COVID or shortly after, you are not imagining it and you are not alone. The biological pathways described above are plausible and supported by evidence, even though researchers are still working out exactly which pathway dominates in different cases.

    Will COVID Tinnitus Go Away? What the Research Actually Shows

    This is the question most people searching this topic most want answered. The honest answer is: it depends on how severe it is.

    The most detailed evidence on this comes from Mao et al. (2024), whose survey of 1,331 post-COVID respondents found a clear severity gradient in outcomes. Mild (Grade I) tinnitus had notably higher rates of spontaneous resolution. Severe tinnitus — classified as Grade IV — had low spontaneous resolution rates and a strong association with long-term hearing loss and anxiety disorders. Grade IV was also the most common severity grade reported, representing 33.2% of all tinnitus cases in the survey.

    This matters for what you do next. If your tinnitus is mild and fading, watchful waiting with good sleep and stress management is reasonable. If it is severe, intrusive, or has not improved after several weeks, waiting longer is unlikely to help and may delay treatment that could.

    A smaller audiometric study of long-COVID patients with hearing complaints found that, at around 259 days post-infection, 7 out of 21 patients who had presented with tinnitus showed full recovery; 14 had only partial recovery or none at all (Dorobisz et al., 2023). This is a small sample and cannot be generalised widely, but it is consistent with the pattern from Mao et al.: a substantial proportion of cases do not resolve without support.

    Hospitalisation history is also a relevant predictor. Research has found that patients who were hospitalised during their COVID illness tend to have worse tinnitus outcomes than those with milder acute illness, with severity correlating significantly with hospitalisation status.

    Severe or persistent tinnitus after COVID is not likely to resolve on its own without support. If your tinnitus has lasted more than a few weeks after your COVID illness and is significantly affecting your daily life or sleep, seek an audiological evaluation rather than waiting indefinitely.

    Importantly, this does not mean severe cases are untreatable. Standard tinnitus management approaches — including cognitive behavioural therapy, sound therapy, and audiological support — can reduce distress and improve function even when spontaneous resolution does not occur. Severity at onset is the best available predictor of whether the tinnitus will resolve on its own; it does not determine whether you can get better with the right support.

    COVID Tinnitus vs. Long COVID Tinnitus: Is There a Difference?

    You may have heard the term “long COVID” and wondered whether it applies to you. Under NICE guidance, long COVID (formally called post-COVID-19 syndrome) is defined as symptoms that develop during or after COVID infection, persist for more than 12 weeks, and cannot be explained by another diagnosis. Tinnitus is explicitly listed as a recognised ENT symptom of long COVID under these guidelines (NICE/SIGN/RCGP, 2024).

    The clinical categories break down like this:

    • Acute COVID: symptoms lasting up to 4 weeks
    • Ongoing symptomatic COVID: symptoms lasting 4 to 12 weeks
    • Post-COVID-19 syndrome (long COVID): symptoms lasting 12 weeks or more

    If your tinnitus has persisted beyond three months after your COVID illness, it qualifies as a recognised long COVID symptom — which matters because it entitles you to appropriate clinical assessment and support rather than being dismissed as something unrelated.

    Long COVID tinnitus may involve a somewhat different biological dynamic than tinnitus that resolves in the acute phase. Persistent systemic inflammation, central sensitisation, and possible autoimmune mechanisms are all proposed contributors. A 2025 narrative review found that approximately 1 in 5 long-COVID patients reports tinnitus (Guntinas-Lichius et al., 2025). Self-reported rates in long-COVID populations are often higher.

    None of this means long COVID tinnitus is untreatable. It does mean it is less likely to resolve without some form of structured support, and more likely to respond well if you seek it.

    What Can You Do If You Have COVID Tinnitus?

    There is no treatment that specifically targets COVID tinnitus as a separate category — the same evidence-based approaches used for tinnitus from any cause apply here (Guntinas-Lichius et al., 2025). The practical steps below are grounded in what the research supports.

    See a GP or ENT if tinnitus has lasted more than a few weeks. Do not wait indefinitely. Ask for a referral for audiological evaluation to check for underlying hearing loss, which may accompany the tinnitus and is worth detecting early.

    Manage the things that make tinnitus louder. Anxiety, poor sleep, and sustained stress are known amplifiers of tinnitus perception — and all three are common during post-COVID recovery. Improving sleep quality and managing anxiety are not just general wellness advice; they have a direct effect on how tinnitus is perceived.

    Standard tinnitus therapies apply. Cognitive behavioural therapy for tinnitus has strong evidence for reducing tinnitus-related distress. Sound therapy and audiological counselling are also established options. Your GP or an audiologist can help you access these.

    If you had tinnitus before COVID and it has worsened, this is also documented and worth raising with a clinician. A small controlled study found that COVID infection itself — not just pandemic stress — significantly worsened tinnitus severity and quality of life in people with pre-existing tinnitus, even without changes in hearing thresholds (Aydogan et al., 2025). You are not imagining a deterioration.

    What This Means for You

    If you came to this article worried about a new ringing in your ears after COVID, here is what the evidence actually shows.

    First, COVID tinnitus is real. It is documented across multiple large studies, officially recognised in clinical guidelines, and not imagined or exaggerated. You are not the only person dealing with this.

    Second, the prognosis is genuinely variable, and severity at onset is the most useful guide. Mild tinnitus that appeared during or shortly after COVID illness often improves over weeks to months. Severe tinnitus — particularly the intrusive, high-grade kind that affects sleep and daily functioning — is less likely to resolve on its own and more likely to need active management. Waiting without seeking help is rarely the right approach if tinnitus is severe or has persisted for weeks.

    Third, this is not an untreatable condition. There is no special “COVID tinnitus treatment,” but there are effective management approaches that work for post-COVID cases just as they do for other forms of tinnitus. Getting an audiological assessment is the right starting point — not because something is necessarily seriously wrong, but because knowing what you are dealing with puts you in a better position to manage it.

    The uncertainty can be hard to sit with. But understanding what is happening, and knowing when to seek support, is a meaningful first step.

  • Tinnitus Symptoms: When Ear Ringing Requires Urgent Medical Attention

    Tinnitus Symptoms: When Ear Ringing Requires Urgent Medical Attention

    That Ringing in Your Ears: When to Worry and When to Wait

    A sudden change in the sounds you hear — or a new ringing, buzzing, or whooshing that wasn’t there before — can be genuinely frightening. The question “is this serious?” is a completely reasonable one to ask. The honest answer is that most tinnitus is not dangerous. But a small number of presentations are time-sensitive, and acting quickly in those cases can make a real difference to your hearing and your health.

    This article walks you through a three-tier decision guide: symptoms that require emergency care right now, symptoms that need specialist review within 24 to 48 hours, and symptoms where a routine GP appointment within two weeks is the right step. Knowing which category fits your situation means you can act calmly and decisively.

    Which Tinnitus Symptoms Are Red Flags?

    Most tinnitus is not dangerous, but certain tinnitus symptoms signal conditions where how quickly you act changes outcomes. Go to A&E or call 999 immediately if you have tinnitus with sudden facial weakness, drooping, or confusion (possible stroke), tinnitus after a head injury, or a new heartbeat-synced whooshing sound (pulsatile tinnitus). See an ENT doctor within 24 hours if you notice sudden hearing loss alongside tinnitus in one ear — steroid treatment works best when started as soon as possible, and the window for effective treatment closes after about two weeks. Book a GP appointment within two weeks for one-sided tinnitus with no obvious cause, tinnitus causing significant sleep disruption or distress, or new persistent tinnitus that has lasted more than a few days.

    Emergency: Go to A&E or Call 999 Now

    The following presentations require immediate emergency department assessment. They are uncommon, but acting the same day matters.

    Sudden facial weakness, drooping, numbness, or confusion alongside tinnitus. These are warning signs of stroke. Use the FAST check: Face drooping, Arm weakness, Speech difficulty, Time to call 999. Tinnitus appearing alongside any of these symptoms is a neurological emergency.

    Tinnitus following a head or neck injury. Even if the injury seemed minor, tinnitus after trauma can indicate a base-of-skull fracture or damage to the structures of the inner ear. An emergency CT scan is needed to assess this (Hoare & et (2022)).

    New-onset pulsatile tinnitus — a heartbeat-synced whooshing or thumping sound that has appeared suddenly. This type of tinnitus can indicate a vascular emergency, including an arteriovenous malformation or arterial dissection. Sudden-onset pulsatile tinnitus warrants emergency MR angiography and should not be waited on (Hoare & et (2022)).

    Acute severe vertigo with neurological symptoms alongside tinnitus. Severe spinning, loss of balance, and difficulty coordinating movement combined with tinnitus can indicate a cerebellar event or stroke. Go to A&E without delay.

    These four presentations are uncommon, but they are the situations where acting immediately, rather than waiting to see a GP in the morning, can be the difference between a good recovery and serious lasting harm.

    Urgent: See an ENT or GP Within 24–48 Hours

    Sudden hearing loss alongside tinnitus in one ear. Sudden sensorineural hearing loss (SSHL) is hearing that drops noticeably over a period of up to 72 hours. It often arrives alongside tinnitus, and sometimes a feeling of ear fullness. Hoare & et (2022) describe SSHL as an “otological emergency” and state that “high-dose oral corticosteroids should be commenced prior to specialist assessment.” Research shows that corticosteroid treatment is most effective when started as soon as possible — the evidence indicates no significant difference in outcomes within the first 14 days, but effectiveness drops dramatically after that point (Frontiers in Neurology (2023)). A meta-analysis of 20 randomised controlled trials confirmed that steroid treatment significantly improves hearing recovery, with combined intratympanic and systemic steroids producing the best results (Li & Ding (2020)). Do not wait to see whether the hearing returns on its own — around one-third to two-thirds of people do recover some hearing without treatment, but those who do not will have a much smaller chance of recovery if treatment is delayed past two weeks.

    Pulsatile tinnitus of any kind. Any rhythmic thumping or whooshing that pulses in time with your heartbeat needs investigation for a vascular cause, even if it didn’t appear suddenly. Around 30–50% of people with pulsatile tinnitus have an identifiable underlying cause, and CT angiography has approximately 86% diagnostic yield in identifying it (Yew (2021)). This is a different diagnostic pathway from a standard hearing test — your doctor needs to know the sound is pulsatile so the right imaging is ordered.

    New one-sided tinnitus with hearing change. Tinnitus in one ear only, particularly when accompanied by any change in hearing, warrants audiometry and a possible MRI of the internal auditory canal. The absolute risk of an acoustic neuroma (vestibular schwannoma) is low — a meta-analysis of 1,394 patients found a detection rate of just 0.08% on MRI for unilateral tinnitus without hearing asymmetry (Javed et al. (2023)) — but detecting even a small tumour early allows conservative monitoring rather than surgery. NICE guidelines recommend considering MRI for unilateral or asymmetric tinnitus even in the absence of other symptoms (NICE Guidelines (2020)).

    Within Two Weeks: Book a GP Appointment

    Not every concerning presentation is an emergency. These situations are clinically important and deserve proper attention, but a routine GP appointment within a fortnight is appropriate.

    Tinnitus causing severe distress, sleep disruption, anxiety, or low mood. Tinnitus and mental health are closely linked — research shows that around 20% of people with tinnitus report suicidal thoughts, compared to approximately 13% in the general population, and depression significantly amplifies that risk (Brüggemann & et (2019)). If you are experiencing thoughts of suicide or self-harm, please contact a crisis line now — call the Samaritans on 116 123 or dial NHS 111. You do not need to wait for a GP appointment to get support.

    Progressive hearing loss developing over days to weeks. Hearing loss that is getting worse gradually, rather than appearing suddenly, still requires ENT assessment and audiometry. It does not carry the same immediate urgency as SSHL, but a two-week window is appropriate — do not leave it for months.

    New tinnitus lasting more than a few days with no obvious cause. If your tinnitus appeared without a clear trigger (no recent loud noise, no ear infection, no new medication), and it has persisted for more than a few days, a GP visit is worth arranging. Many reversible causes exist — earwax build-up, blood pressure changes, and medication side effects among them. Catching these early usually means simpler management.

    The 48-Hour and 72-Hour Rules: Why Timing Matters

    You may have seen references to a “72-hour window” for tinnitus and hearing loss. The reality is a little more precise, and understanding it helps explain why the urgency tiers above are structured as they are.

    With sudden sensorineural hearing loss, the cochlea’s hair cells and auditory nerve can be injured by reduced blood supply or inflammation. Corticosteroids reduce that inflammation — but they work best when given early. The research shows that there is no significant difference in treatment outcomes when steroids are started any time within the first 14 days. After 14 days, however, the effectiveness of steroid treatment drops sharply (Frontiers in Neurology (2023)). This is why SSHL is treated like a cardiac event: not because every hour counts in the same way a heart attack does, but because the treatment window is real and finite, and waiting to see whether the hearing comes back on its own risks closing that window permanently.

    With pulsatile tinnitus, the urgency is different in character. Some causes — like a benign venous hum — are not dangerous. Others, including arteriovenous fistulas or arterial dissection, carry a risk of stroke or haemorrhage that can worsen rapidly (Yew (2021)). This is why pulsatile tinnitus goes straight to vascular imaging rather than a standard audiogram. The goal is not to alarm you, but to identify the small proportion of cases where the underlying cause is serious before it progresses.

    Summary: A Quick-Reference Guide to Tinnitus Red Flags

    Here is a plain-language summary you can return to quickly.

    EMERGENCY — call 999 or go to A&E now:

    • Tinnitus after a head or neck injury
    • Sudden facial weakness, drooping, or confusion (stroke symptoms)
    • A new heartbeat-synced whooshing sound (sudden pulsatile tinnitus)
    • Acute severe vertigo with neurological signs
    • Tinnitus with thoughts of suicide or self-harm (call Samaritans: 116 123 or NHS 111)

    URGENT — see an ENT or GP within 24–48 hours:

    ROUTINE GP — within two weeks:

    • Tinnitus causing significant distress, anxiety, or sleep disruption
    • Gradually worsening hearing over days to weeks
    • New persistent tinnitus with no obvious cause

    For most people, tinnitus is not a sign of anything dangerous. But knowing when to act quickly means you are equipped to protect your hearing and your health when it counts.

  • Ringing in One Ear Only: Causes, Red Flags, and Next Steps

    Ringing in One Ear Only: Causes, Red Flags, and Next Steps

    That Ringing Is Only in One Ear — Here’s Why That Matters

    Hearing a sound in one ear while the other stays quiet feels different from ordinary tinnitus. Most people find the asymmetry unsettling in a way that bilateral ringing isn’t — and that instinct is worth paying attention to. One-sided tinnitus does warrant closer attention than tinnitus in both ears, but the important thing to know upfront is that most causes are benign and many are fully reversible.

    This article breaks down the causes of ringing in one ear in a way that most sources don’t: by urgency. You’ll find out which causes are common and easily treated, which ones need investigation but aren’t emergencies, and which specific warning signs mean you should seek same-day care. You’ll also get a clear picture of what a clinical workup actually looks like, so you know what to expect if you do see a doctor.

    What Causes Ringing in One Ear Only?

    Ringing in one ear only (unilateral tinnitus) is most commonly caused by earwax blockage, an ear infection, or noise exposure affecting one side — all of which are reversible with treatment. Less frequently, it signals inner ear conditions like Ménière’s disease or otosclerosis. Acoustic neuroma (a benign tumour on the hearing nerve) is the serious cause people worry about most, but it accounts for roughly 1–3% of cases in people who also have asymmetric hearing loss (Abbas et al., 2018); in unilateral tinnitus without hearing loss, the detection rate from MRI screening is just 0.08% (Javed et al., 2023). If the ringing started suddenly and came with hearing loss, treat it as urgent: the treatment window for sudden sensorineural hearing loss is narrow, and referral within 24 hours gives you the best chance of recovery (NICE, 2020).

    The Most Common Causes: Benign and Often Reversible

    The majority of people who notice ringing in one ear have a cause that resolves with straightforward treatment or on its own.

    Earwax (cerumen) impaction — A build-up of wax in one ear canal changes the pressure environment and how sound reaches the cochlea, which can produce a phantom sound on that side. This is one of the most common causes of sudden-onset unilateral tinnitus. If an otoscope shows a blockage, professional earwax removal (microsuction or irrigation) often resolves it quickly. Don’t use cotton buds to clear it yourself — they push wax deeper.

    Ear infection (otitis media or externa) — Fluid behind the eardrum or inflammation in the outer ear canal on one side disrupts normal sound transmission. The ringing usually fades once the infection clears, with or without antibiotics depending on the type. See a GP if you have ear pain, discharge, or fever alongside the ringing.

    Asymmetric noise exposure — Standing with one ear closer to a speaker at a concert, using a single earbud for long periods, or a sudden acoustic event on one side (a gunshot, an explosion) can damage the hair cells in one cochlea while leaving the other intact. The resulting tinnitus may be temporary if the exposure was short. Avoid further loud noise while it settles and let a GP or audiologist assess if it persists beyond a few days.

    Eustachian tube dysfunction — A cold, allergy, or rapid altitude change can create a pressure imbalance on one side. The tinnitus here tends to feel muffled rather than sharp, and often resolves once the congestion clears. Decongestants and nasal steroids can help; see a GP if it lasts more than a few weeks.

    Causes That Need Investigation — Not an Emergency, but Don’t Ignore Them

    Some causes of one-sided tinnitus are less common and require a proper clinical assessment, but they are manageable once identified. None of the following require a same-day emergency visit unless you also have sudden hearing loss or neurological symptoms.

    Ménière’s disease — Classic Ménière’s starts in one ear and produces a distinctive cluster: low-pitched rumbling or roaring tinnitus, a sensation of fullness in the ear, episodes of vertigo, and fluctuating hearing loss. The tinnitus can precede other symptoms by months. Early diagnosis matters because without management the hearing loss can become permanent over time. If you have any combination of these features, an ENT referral is the right step.

    Otosclerosis — Abnormal bone growth in the middle ear that stiffens the ossicular chain and gradually reduces hearing. It tends to start on one side and is more common in women. Tinnitus is often an early symptom. Surgery (stapedectomy) is highly effective when the condition is identified.

    TMJ disorder — The temporomandibular joint sits directly in front of the ear canal. Jaw tension, grinding, or joint dysfunction can refer symptoms into the ear on one side, producing tinnitus that may worsen with jaw movement or chewing. A dentist or maxillofacial specialist can assess this. Management typically involves bite guards, physiotherapy, or stress reduction.

    Acoustic neuroma (vestibular schwannoma) — This is the diagnosis many people fear when they search for unilateral tinnitus. It is worth understanding clearly. An acoustic neuroma is a benign, slow-growing tumour on the vestibulocochlear nerve. It typically develops gradually over months or years, with progressive one-sided hearing loss alongside the tinnitus. In patients referred for assessment with both asymmetric hearing loss and unilateral tinnitus, about 2.22% are found to have one on MRI (Abbas et al., 2018). In people with unilateral tinnitus but normal hearing, the pooled detection rate from MRI screening is just 0.08% (Javed et al., 2023). So while ruling it out matters, it is not the most likely explanation for most people who come searching with this symptom.

    Red Flag Symptoms: When to Act Urgently

    Most one-sided tinnitus does not require emergency care. The following presentations are the exceptions. What makes them different is that early action changes outcomes.

    Sudden onset with hearing loss — If you noticed the ringing and hearing loss developing over hours or up to three days, and this happened within the past 30 days, NICE (2020) recommends referral to be seen within 24 hours. The reason is sudden sensorineural hearing loss (SSHL): a medical situation where rapid-onset inner ear damage may be partially reversible with corticosteroid treatment, but only if treatment starts promptly. The optimal window is within 72 hours; the guideline-sanctioned window extends to two weeks, but outcomes decline the longer treatment is delayed. Don’t wait for a routine GP appointment. Go that day.

    Pulsatile tinnitus — If the sound in your ear beats in time with your heartbeat rather than being a constant tone, this is pulsatile tinnitus. It suggests a vascular cause rather than an inner ear or neural one. Possible explanations include arteriovenous malformation, dural venous sinus stenosis, or vascular tumours (Wang et al., 2024). Pulsatile tinnitus needs a different investigation pathway: CT angiography or MRI rather than a standard hearing test. Mention explicitly to your doctor that the sound pulses with your heartbeat.

    Tinnitus with facial weakness, numbness, or drooping — This combination can indicate nerve compression or, in the most urgent scenario, stroke. If you have any neurological symptoms alongside new tinnitus, call emergency services or go to A&E immediately. NICE (2020) specifies immediate same-day emergency referral for tinnitus presenting alongside acute focal neurological signs.

    Tinnitus after a head injury — Any new tinnitus following head or neck trauma warrants same-day assessment, as it may accompany inner ear damage or intracranial injury.

    These presentations are uncommon. But they are the ones where acting quickly has a direct effect on what treatment is available to you.

    The Diagnostic Pathway: What to Expect When You See a Doctor

    Knowing what happens at each stage can make the process feel less daunting.

    GP or primary care visit — Your doctor will take a history (how long the ringing has been there, whether it’s constant or intermittent, any other symptoms), examine your ear canal with an otoscope to look for earwax, infection, or perforation, and check your blood pressure. Based on findings, they’ll decide whether to treat directly, refer to audiology, or refer to ENT.

    Audiologist — A pure-tone audiometry test checks for asymmetric hearing loss — hearing that is measurably worse in one ear than the other. Asymmetric hearing loss is itself a clinical red flag that typically prompts onward referral for imaging.

    ENT specialist — If you have asymmetric hearing loss, unilateral tinnitus without a clear benign cause, or pulsatile tinnitus, an ENT may request MRI with gadolinium contrast, which is the standard imaging test for ruling out acoustic neuroma. For pulsatile presentations, CT angiography is the preferred first imaging step (Wang et al., 2024). The AAFP (2021) guideline supports MRI for unilateral tinnitus with asymmetric hearing loss.

    Most people who go through this process are discharged after audiometry with a management plan. Imaging referral is a precaution taken in a minority of cases — not the default outcome for everyone with ringing in one ear.

    Key Takeaways

    • Ringing in one ear only warrants earlier medical attention than bilateral tinnitus, but most causes — earwax, ear infection, and asymmetric noise exposure — are benign and treatable.
    • Sudden onset with hearing loss is a time-sensitive situation: seek same-day assessment, because early corticosteroid treatment (within 72 hours, ideally) gives the best chance of recovery (NICE, 2020).
    • Pulsatile tinnitus — a beating sound in time with your heartbeat — needs a different investigation pathway (CT angiography or MRI) rather than a standard hearing test.
    • Acoustic neuroma accounts for roughly 2% of cases in people with asymmetric hearing loss and unilateral tinnitus (Abbas et al., 2018), and just 0.08% in those with normal hearing (Javed et al., 2023) — important to rule out, but not the most likely explanation.
    • Tinnitus alongside facial weakness, numbness, or other neurological symptoms is an emergency — call for help immediately.

    Seeing a GP or audiologist promptly is the right move — not because something serious is likely, but because finding out quickly means better options.

  • Right Ear Ringing: Medical Causes, Red Flags, and When to Worry

    Right Ear Ringing: Medical Causes, Red Flags, and When to Worry

    That Ringing in Your Right Ear: Why One Side Matters

    A sudden ringing, buzzing, or hissing in your right ear — and only your right ear — is the kind of thing that’s hard to ignore. It’s unsettling, especially when there’s no obvious reason for it. Many people search for a meaning behind the fact that it’s specifically the right ear, and that’s a completely understandable impulse. From a medical standpoint, though, the side of your head matters less than the fact that it’s only one side. That distinction is what this article is about: what causes one-sided ringing, when it signals something that needs attention, and how to tell the difference.

    What Does Ringing in the Right Ear Mean?

    Ringing in the right ear is medically the same as ringing in either ear — the right side carries no special clinical significance over the left. What does matter is that it’s only one ear. Unilateral tinnitus (ringing in one ear) is more clinically significant than bilateral tinnitus (ringing in both ears), because persistent one-sided ringing without an obvious cause — such as recent loud noise exposure or earwax — warrants audiometry and possibly an MRI to rule out rare but serious conditions like acoustic neuroma. Most cases have benign, treatable causes. But the one-sidedness is the detail a doctor needs to hear.

    Common Medical Causes of Right Ear Ringing

    Most cases of ringing in one ear have an identifiable, treatable cause. Here are the most common.

    Earwax buildup is the most frequently overlooked cause of unilateral tinnitus. Wax doesn’t accumulate symmetrically — one ear canal can become partially or fully blocked while the other remains clear, creating ringing, muffled hearing, or a sense of pressure on just one side. It’s also one of the easiest problems to fix.

    Noise-induced hearing loss typically affects both ears, but not always. Asymmetric noise exposure — from shooting sports where one ear faces the muzzle blast, from using headphones with the volume higher on one side, or from a single loud event close to one ear — can damage the hearing cells on one side more than the other, producing one-sided ringing.

    Ear infection or middle ear fluid (otitis media, or Eustachian tube dysfunction) commonly affects one ear at a time. Fluid behind the eardrum dampens sound transmission and can trigger tinnitus on the affected side. This often resolves once the underlying infection or blockage clears.

    Ménière’s disease is a condition of the inner ear that classically presents on one side only. The full picture includes episodes of spinning vertigo, fluctuating hearing loss, a feeling of fullness or pressure in the ear, and tinnitus — all on the same side. It’s not common, but if your ringing comes with any of those accompanying symptoms, it’s worth raising with your doctor.

    TMJ (temporomandibular joint) disorder is a less obvious cause that’s worth knowing about. The jaw joint sits very close to the ear canal, and dysfunction or inflammation on the right side of the jaw can refer symptoms — including ringing or a clicking sensation — to the right ear. If you’ve noticed jaw pain, clicking when you chew, or tension in your face alongside the tinnitus, a dental or maxillofacial assessment may be relevant.

    Ototoxic medications — certain drugs that can damage the inner ear — include some antibiotics (particularly aminoglycosides), some chemotherapy agents, and high-dose aspirin. These usually affect both ears, but occasionally the damage is asymmetric, producing one-sided or more prominent tinnitus on one side. If you’ve recently started a new medication and noticed the ringing shortly afterwards, mention it to your doctor.

    Why One Ear Only? The Diagnostic Significance of Laterality

    When a doctor assesses tinnitus, two questions come before everything else: Is it one ear or both? And does the sound pulse in time with the heartbeat, or is it a steady tone?

    These two axes — laterality and pulsatility — determine the entire diagnostic pathway.

    Laterality matters because most structural causes of tinnitus (problems with specific anatomical structures rather than general noise damage) tend to affect one side. Acoustic neuroma — a benign, slow-growing tumour on the hearing nerve, also called vestibular schwannoma — is the condition doctors most want to rule out in persistent unilateral tinnitus. The good news: it is rare. A meta-analysis of 1,394 patients who had an MRI specifically for unilateral tinnitus without asymmetric hearing loss found a vestibular schwannoma detection rate of just 0.08% (Javed et al., 2023). The risk is higher when hearing loss is also present on the same side — one prospective study at a specialist referral centre found acoustic neuroma in around 2.22% of patients with asymmetric hearing loss and/or unilateral tinnitus (Abbas et al., 2018). This is why audiometry comes first: a hearing test tells the doctor whether asymmetric hearing loss is present, which in turn informs whether an MRI is warranted.

    Pulsatility opens a different set of questions entirely. If the ringing beats in time with your heartbeat — if you can feel your pulse in the sound — this is called pulsatile tinnitus, and it points toward vascular causes rather than auditory nerve causes. A review of 251 patients with pulsatile tinnitus found identifiable causes including vascular tumours (16%), arterial abnormalities (14%), and venous channel problems (8.5%), with around half having no identifiable cause (Lynch et al., 2022). The diagnostic pathway for pulsatile tinnitus requires imaging of the blood vessels — MRI/MRA or CT angiography — not just an audiogram (AAFP, 2021).

    The practical upshot: non-pulsatile one-sided tinnitus leads to a hearing test and possibly an MRI of the auditory canal. Pulsatile one-sided tinnitus leads to vascular imaging. These are different investigations for different questions.

    Red Flags: When Right Ear Ringing Requires Urgent Action

    The majority of people with unilateral tinnitus do not need emergency care. Most cases are managed in primary care without any specialist investigation. The red flags below are the exceptions.

    Seek emergency care immediately

    Go to A&E or an emergency room without delay if:

    • The ringing appeared after a head or neck injury — this may indicate a base-of-skull fracture or vascular injury requiring urgent imaging.
    • The ringing is accompanied by sudden facial weakness, numbness, speech difficulty, or vision changes. These may indicate a stroke. Apply the FAST test (Face, Arms, Speech, Time) and call emergency services.
    • New pulsatile tinnitus came on suddenly alongside a severe headache. This combination warrants immediate vascular assessment (Ralli et al., 2022).

    See a doctor within 24 hours

    • Sudden hearing loss in the right ear alongside the ringing. This is called sudden sensorineural hearing loss (SSHL) — a rapid loss of inner-ear function that requires prompt treatment. Corticosteroids offer the best chance of recovery, and treatment should begin as soon as possible after onset, ideally within the first few days; benefit has been reported up to two weeks after onset (Ralli et al., 2022). Do not wait for a routine appointment.
    • New pulsatile tinnitus of any kind (without the emergency symptoms above). Even without other red flags, this requires vascular imaging rather than a standard hearing test, and the sooner it’s investigated, the better.

    See your GP within two weeks

    To be clear: the emergency and 24-hour categories are uncommon. If your tinnitus arrived gradually, stays constant (not pulsing), and has no accompanying symptoms, the two-week GP pathway is almost certainly the right one.

    What to Expect at Your Doctor’s Appointment

    If you’ve never consulted a doctor about tinnitus before, knowing what to expect can make the appointment feel less daunting.

    Your GP or ENT specialist will start with questions: When did the ringing start? Does it pulse or is it a steady tone? Have you noticed any hearing change? Any recent loud noise exposure? Any new medications? Any dizziness or ear fullness? These aren’t box-ticking questions — the answers directly shape which tests, if any, are needed.

    The physical examination usually includes otoscopy (a look inside the ear canal with a small light) to check for wax, infection, or structural abnormalities. Your doctor may also perform simple tuning fork tests to get a rough sense of whether there’s a conductive or sensorineural hearing component.

    If no obvious benign cause emerges, the next step is a formal hearing test (audiometry), usually via referral to an audiologist or ENT clinic. The AAFP (2021) guideline recommends referral within four weeks for unilateral or bothersome tinnitus. If audiometry reveals asymmetric hearing loss on the affected side — or if no cause is found and the tinnitus persists — an MRI of the auditory canal may follow.

    Most cases are resolved or managed at the primary care level. You are unlikely to leave your first appointment with a serious diagnosis.

    Most right ear ringing has a benign cause. The key questions are whether it’s pulsatile (heartbeat-synced) and whether it comes with hearing loss on the same side — these two features determine which investigations are needed.

    The Bottom Line on Right Ear Ringing

    Most ringing in the right ear has a benign cause — earwax, noise exposure, a minor ear infection, or jaw tension are far more common than anything serious. What makes one-sided ringing worth taking seriously is its persistence and any accompanying symptoms: hearing loss on the same side, a pulsing quality, or sudden onset without explanation. The red flags in this article are your guide to when and how fast to act. Knowing the difference between a “see your GP this week” situation and a “go to A&E now” situation means you can respond clearly rather than anxiously. Most people reading this will fall firmly in the “see your GP” category — and that’s a manageable, solvable problem.

  • Tinnitus Research Digest: Treatment-Resistant Inner Ear Disease, Music Perception, and Brain Plasticity

    This week’s digest covers four items across tinnitus and inner ear research: a new Chinese clinical consensus on conditions that resist standard treatment, a study on music perception difficulties in tinnitus patients with normal audiograms, an older review of the brain changes thought to drive tinnitus, and a preclinical study on how the basal ganglia may affect sound filtering. The items range from clinically applicable to basic science with no immediate treatment implications.

Subscribe to Our Tinnitus Newsletter

  • Learn everything about tinnitus causes, myths, and treatments
  • Get the latest tinnitus research delivered to your inbox every week

You can unsubscribe anytime.

Subscribe Now